BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Emile JF, Abla O, Fraitag S, Horne A, Haroche J, Donadieu J, Requena-Caballero L, Jordan MB, Abdel-Wahab O, Allen CE, Charlotte F, Diamond EL, Egeler RM, Fischer A, Herrera JG, Henter JI, Janku F, Merad M, Picarsic J, Rodriguez-Galindo C, Rollins BJ, Tazi A, Vassallo R, Weiss LM; Histiocyte Society. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages. Blood. 2016;127:2672-2681. [PMID: 26966089 DOI: 10.1182/blood-2016-01-690636] [Cited by in Crossref: 533] [Cited by in F6Publishing: 448] [Article Influence: 88.8] [Reference Citation Analysis]
Number Citing Articles
1 Ramon A, Greigert H, Ornetti P, Bonnotte B, Samson M. Mimickers of Large Vessel Giant Cell Arteritis. JCM 2022;11:495. [DOI: 10.3390/jcm11030495] [Reference Citation Analysis]
2 Kirschenbaum D, Woernle C, Haralambieva E, Marques Maggio E, Bernays R, Camenisch U, Rushing EJ. A 72-year old female with multiple supra- and infratentorial dural masses. Brain Pathol 2018;28:1023-4. [PMID: 30536772 DOI: 10.1111/bpa.12666] [Reference Citation Analysis]
3 Li JJ, Talam S, Star P, Getta B. Atypical cutaneous histiocytic eruption in a patient with chronic myelomonocytic leukemia: A case report. J Cutan Pathol 2021;48:680-8. [PMID: 33416192 DOI: 10.1111/cup.13957] [Reference Citation Analysis]
4 Marinelli JP, Peters PA, Vaglio A, Van Gompel JJ, Lane JI, Carlson ML. Skull Base Manifestations of Erdheim-Chester Disease: A Case Series and Systematic Review. Neurosurgery 2019;85:E693-701. [DOI: 10.1093/neuros/nyz027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
5 Kiratli H, Koç I, Söylemezoğlu F. [Erdheim-Chester disease presenting with bilateral orbital involvement: Report of three cases]. J Fr Ophtalmol 2020;43:851-7. [PMID: 32829941 DOI: 10.1016/j.jfo.2019.11.045] [Reference Citation Analysis]
6 Palmblad K, Schierbeck H, Sundberg E, Horne AC, Erlandsson Harris H, Henter JI, Andersson U. Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome. Mol Med 2021;27:48. [PMID: 33975537 DOI: 10.1186/s10020-021-00308-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Reisi N, Raeissi P, Harati Khalilabad T, Moafi A. Unusual sites of bone involvement in Langerhans cell histiocytosis: a systematic review of the literature. Orphanet J Rare Dis 2021;16:1. [PMID: 33388073 DOI: 10.1186/s13023-020-01625-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Eltilib M, Fenner J, Saramago I, Oldan J. Necrobiotic Xanthogranuloma on 18F-FDG PET/CT. Clin Nucl Med 2020;45:967-9. [PMID: 32969908 DOI: 10.1097/RLU.0000000000003300] [Reference Citation Analysis]
9 Rossi G, Cavazza A, Spagnolo P, Bellafiore S, Kuhn E, Carassai P, Caramanico L, Montanari G, Cappiello G, Andreani A, Bono F, Nannini N. The role of macrophages in interstitial lung diseases: Number 3 in the Series “Pathology for the clinician” Edited by Peter Dorfmüller and Alberto Cavazza. Eur Respir Rev 2017;26:170009. [DOI: 10.1183/16000617.0009-2017] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
10 Karadag AS, Tekin B, Hurdogan O, Dagdelen D, Dogan O, Buyukbabani N. A case report demonstrating potential utility of topical imiquimod for cutaneous Rosai-Dorfman disease. Dermatol Ther 2019;32:e12759. [PMID: 30288863 DOI: 10.1111/dth.12759] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Schulert GS, Cron RQ. The genetics of macrophage activation syndrome. Genes Immun 2020;21:169-81. [PMID: 32291394 DOI: 10.1038/s41435-020-0098-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 10.0] [Reference Citation Analysis]
12 Berberi A, Aoun G, Aad G, Azar E. Isolated Bone Lesions in the Mandible and Maxilla of Langerhans Cell Histiocytosis Treated with Fractionated Stereotactic Low-Dose Radiotherapy: Case Report and 5-Year Follow-Up. Case Rep Dent 2021;2021:9972240. [PMID: 34394998 DOI: 10.1155/2021/9972240] [Reference Citation Analysis]
13 Montefusco L, Harari S, Elia D, Rossi A, Specchia C, Torre O, Adda G, Arosio M. Endocrine and metabolic assessment in adults with Langerhans cell histiocytosis. European Journal of Internal Medicine 2018;51:61-7. [DOI: 10.1016/j.ejim.2017.11.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Pathania V, Sandhu S, Sengupta P, Pudasaini N. Generalized eruptive histiocytosis in an elderly female: A rare entity managed with PUVA therapy. Dermatol Ther 2020;33:e14324. [PMID: 32954599 DOI: 10.1111/dth.14324] [Reference Citation Analysis]
15 Schwentner R, Jug G, Kauer MO, Schnöller T, Waidhofer-Söllner P, Holter W, Hutter C. JAG2 signaling induces differentiation of CD14+ monocytes into Langerhans cell histiocytosis-like cells. J Leukoc Biol 2019;105:101-11. [PMID: 30296338 DOI: 10.1002/JLB.1A0318-098R] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
16 Hoyt BS, Yan S, Linos KD, Momtahen S, Sriharan A, Tran TN, Tsongalis GJ, O'meara RR, Green DC, Leblanc RE. BRAF V600E mutations are not an oncogenic driver of solitary xanthogranuloma and reticulohistiocytoma: Testing may be useful in screening for Erdheim-Chester disease. Experimental and Molecular Pathology 2019;111:104320. [DOI: 10.1016/j.yexmp.2019.104320] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Agarwal P, Tejwani N, Ahmad R, Mehta A. Non Cutaneous, Non Langerhans Cell Histiocytoses: A Diagnostic Dilemma. Indian J Hematol Blood Transfus 2018;34:553-5. [PMID: 30127573 DOI: 10.1007/s12288-018-0925-1] [Reference Citation Analysis]
18 La Rosée P, Horne A, Hines M, von Bahr Greenwood T, Machowicz R, Berliner N, Birndt S, Gil-Herrera J, Girschikofsky M, Jordan MB, Kumar A, van Laar JAM, Lachmann G, Nichols KE, Ramanan AV, Wang Y, Wang Z, Janka G, Henter JI. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood 2019;133:2465-77. [PMID: 30992265 DOI: 10.1182/blood.2018894618] [Cited by in Crossref: 212] [Cited by in F6Publishing: 186] [Article Influence: 70.7] [Reference Citation Analysis]
19 Donadieu J, Tazi A. [Histiocytosis: Better understanding for better care]. Presse Med 2017;46:43-5. [PMID: 27816337 DOI: 10.1016/j.lpm.2016.09.017] [Reference Citation Analysis]
20 Gulati N, Allen CE. Langerhans cell histiocytosis: Version 2021. Hematol Oncol 2021;39 Suppl 1:15-23. [PMID: 34105821 DOI: 10.1002/hon.2857] [Reference Citation Analysis]
21 Abla O. Finding active LCH cells in the blood. Blood 2017;130:1874-5. [DOI: 10.1182/blood-2017-09-805424] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
22 Vallurupalli M, Berliner N. Emapalumab for the treatment of relapsed/refractory hemophagocytic lymphohistiocytosis. Blood 2019;134:1783-6. [PMID: 31537529 DOI: 10.1182/blood.2019002289] [Cited by in Crossref: 55] [Cited by in F6Publishing: 51] [Article Influence: 27.5] [Reference Citation Analysis]
23 Eissa SS, Clay MR, Santiago T, Wu G, Wang L, Shulkin BL, Picarsic J, Nichols KE, Campbell PK. Dasatinib induces a dramatic response in a child with refractory juvenile xanthogranuloma with a novel MRC1-PDGFRB fusion. Blood Adv 2020;4:2991-5. [PMID: 32609843 DOI: 10.1182/bloodadvances.2020001890] [Reference Citation Analysis]
24 Davick JJ, Kim J, Wick MR, Gru AA. Indeterminate Dendritic Cell Tumor: A Report of Two New Cases Lacking the ETV3-NCOA2 Translocation and a Literature Review. Am J Dermatopathol 2018;40:736-48. [PMID: 29877893 DOI: 10.1097/DAD.0000000000001191] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 4.7] [Reference Citation Analysis]
25 Wang Z. [Recognition of malignant histiocytoses]. Zhonghua Xue Ye Xue Za Zhi 2017;38:806-8. [PMID: 29081203 DOI: 10.3760/cma.j.issn.0253-2727.2017.09.017] [Reference Citation Analysis]
26 AlKuwaity KW, Alosaimi MH, Alsahlawi KT, Alomair MA, Battyour MA, Alkuwaity DW, Buzeid MA, Alsaqer DS. Unusual Presentation of Rosai-Dorfman Disease: Report of a Rare Case. Am J Case Rep 2019;20:91-6. [PMID: 30666043 DOI: 10.12659/AJCR.912423] [Reference Citation Analysis]
27 Razanamahery J, Samson M, Guy J, Francois S, Emile J, Cohen Aubart F, Papo M, Haroche J, Audia S, Bonnotte B. La répartition des sous-populations monocytaire dans l’histiocytose est proche de la leucémie myélomonocytaire chronique, est corrélée au phénotype et à l’activité de la maladie. La Revue de Médecine Interne 2021;42:A326-7. [DOI: 10.1016/j.revmed.2021.10.289] [Reference Citation Analysis]
28 Gupta GK, Xi L, Pack SD, Jones JB, Pittaluga S, Raffeld M, Jaffe ES. ALK-positive histiocytosis with KIF5B-ALK fusion in an adult female. Haematologica 2019;104:e534-6. [PMID: 31371408 DOI: 10.3324/haematol.2019.230094] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
29 Zhou X, Zhu H, Yao Y, Lian X, Feng F, Wang L, Liu S, Deng K, You H, Yang H, Lu L. Etiological Spectrum and Pattern of Change in Pituitary Stalk Thickening: Experience in 321 Patients. J Clin Endocrinol Metab 2019;104:3419-27. [PMID: 30892632 DOI: 10.1210/jc.2018-02297] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
30 Flores-terry M, Sanz-trenado J, García-arpa M, Cortina-de la Calle M. Cutaneous Langerhans Cell Histiocytosis Presenting in Adulthood. Actas Dermo-Sifiliográficas (English Edition) 2019;110:167-9. [DOI: 10.1016/j.adengl.2018.12.005] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
31 Haroche J, Cohen-Aubart F, Emile JF, Donadieu J, Amoura Z. Neurodegeneration in histiocytoses might start in utero. Lancet Neurol 2017;16:953-4. [PMID: 29111143 DOI: 10.1016/S1474-4422(17)30373-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Chellapandian D, Hines MR, Zhang R, Jeng M, van den Bos C, Santa-María López V, Lehmberg K, Sieni E, Wang Y, Nakano T, Williams JA, Fustino NJ, Astigarraga I, Dunkel IJ, Abla O, van Halteren AGS, Pei D, Cheng C, Weitzman S, Sung L, Nichols KE. A multicenter study of patients with multisystem Langerhans cell histiocytosis who develop secondary hemophagocytic lymphohistiocytosis. Cancer 2019;125:963-71. [PMID: 30521100 DOI: 10.1002/cncr.31893] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
33 Nóbrega PR, Rodrigues PGB, de Sousa Pereira I, de Figueiredo Santos C, Gerson G, de Arruda JAM, Júnior JWLT, de Araújo Coimbra PP, Braga-Neto P. Steroid responsive cavernous sinus syndrome due to Rosai-Dorfman disease: beyond Tolosa-Hunt syndrome - a case report. BMC Neurol 2021;21:264. [PMID: 34225703 DOI: 10.1186/s12883-021-02255-z] [Reference Citation Analysis]
34 Tóth B, Kiss N, Hársing J, Kárpáti S, Csomor J, Bödör C, Tímár J, Rásó E. Frequent KIT mutations in skin lesions of patients with BRAF wild-type Langerhans cell histiocytosis. Virchows Arch 2020;477:749-53. [PMID: 32372223 DOI: 10.1007/s00428-020-02820-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
35 Huang H, Lu T, Sun Y, Li S, Li J, Xu K, Feng RE, Xu ZJ. Association between clinicopathologic characteristics and BRAFV600E expression in Chinese patients with Langerhans cell histiocytosis. Thorac Cancer 2019;10:1984-92. [PMID: 31441596 DOI: 10.1111/1759-7714.13179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
36 Wang JN, Wang FD, Sun J, Liang ZY, Li J, Zhou DB, Tian X, Cao XX. Pulmonary manifestations of Erdheim-Chester disease: clinical characteristics, outcomes and comparison with Langerhans cell histiocytosis. Br J Haematol 2021;194:1024-33. [PMID: 34423426 DOI: 10.1111/bjh.17712] [Reference Citation Analysis]
37 Jezierska M, Stefanowicz J, Romanowicz G, Kosiak W, Lange M. Langerhans cell histiocytosis in children - a disease with many faces. Recent advances in pathogenesis, diagnostic examinations and treatment. Postepy Dermatol Alergol 2018;35:6-17. [PMID: 29599667 DOI: 10.5114/pdia.2017.67095] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
38 Kinoshita M, Ogawa Y, Honobe A, Tomita O, Oishi N, Shimada S, Kondo T, Kawamura T. Expression of CD1 molecules and colony-stimulating factor 1 receptor in indeterminate cell histiocytosis. J Dermatol 2021;48:1086-9. [PMID: 33774864 DOI: 10.1111/1346-8138.15857] [Reference Citation Analysis]
39 Awada G, Seremet T, Fostier K, Everaert H, Neyns B. Long-term disease control of Langerhans cell histiocytosis using combined BRAF and MEK inhibition. Blood Adv 2018;2:2156-8. [PMID: 30154124 DOI: 10.1182/bloodadvances.2018021782] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
40 Oliveira CC, Paschoalini RB, Domingues MAC. Fas-ligand and caspase-3 positivity in three cases of histiocytic sarcoma: a different etiopathogenic pathway? Autops Case Rep 2018;8:e2018001. [PMID: 29515976 DOI: 10.4322/acr.2018.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Ghobadi A, Miller CA, Li T, O'Laughlin M, Lee YS, Ali M, Westervelt P, DiPersio JF, Wartman L. Shared cell of origin in a patient with Erdheim-Chester disease and acute myeloid leukemia. Haematologica 2019;104:e373-5. [PMID: 30923101 DOI: 10.3324/haematol.2019.217794] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
42 Zhang X, Wang LP, Ziober A, Zhang PJ, Bagg A. Ionized Calcium Binding Adaptor Molecule 1 (IBA1). Am J Clin Pathol 2021;156:86-99. [PMID: 33582751 DOI: 10.1093/ajcp/aqaa209] [Reference Citation Analysis]
43 Nicholas PD 3rd, Garrahy I. A case of multisystem Langerhans cell histiocytosis presenting as central diabetes insipidus. J Community Hosp Intern Med Perspect 2019;9:515-7. [PMID: 32002162 DOI: 10.1080/20009666.2019.1698231] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Lang C, Maul J, Krähenbühl L, Dimitriou F, Dummer R. Histiozytäre Neoplasien im Kontext der aktuellen Klassifikation. Hautarzt 2019;70:691-9. [DOI: 10.1007/s00105-019-4460-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
45 Hu PP, Wei F, Liu XG, Liu ZJ. Diagnosis and treatment of Rosai-Dorfman disease of the spine: a systematic literature review. Syst Rev 2021;10:31. [PMID: 33461611 DOI: 10.1186/s13643-021-01581-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
46 Di Stefano G, Granai M, Giudici F, Roselli G, Lazzi S, Santi R. Xanthomatous Inflammatory Infiltrate Involving the Spleen: An Unusual Presentation of Erdheim-Chester Disease and Review of the Literature. Am J Case Rep 2021;22:e931060. [PMID: 34083501 DOI: 10.12659/AJCR.931060] [Reference Citation Analysis]
47 Leclerc-Mercier S. How to Deal with Skin Biopsy in an Infant with Blisters? Dermatopathology (Basel) 2021;8:159-75. [PMID: 34199848 DOI: 10.3390/dermatopathology8020022] [Reference Citation Analysis]
48 Egan C, Jaffe ES. Non-neoplastic histiocytic and dendritic cell disorders in lymph nodes. Semin Diagn Pathol 2018;35:20-33. [PMID: 29150219 DOI: 10.1053/j.semdp.2017.11.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
49 Desai CK, Hayes SN, Shah MV, Maleszewski JJ, Bleeker J, Steffen K, Stys M. Extranodal Rosai-Dorfman Disease Presenting as a Pericardial Mass and Constrictive Pericarditis. JACC Case Rep 2019;1:643-7. [PMID: 34316897 DOI: 10.1016/j.jaccas.2019.10.011] [Reference Citation Analysis]
50 Schwentner R, Kolenová A, Jug G, Schnöller T, Ahlmann M, Meister B, Lehrnbecher T, Minkov M, Hutter C. Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis. Pediatr Res 2019;85:856-64. [DOI: 10.1038/s41390-018-0238-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
51 Massoth LR, Hung YP, Ferry JA, Hasserjian RP, Nardi V, Nielsen GP, Sadigh S, Venkataraman V, Selig M, Friedmann AM, Samore W, Killian JK, Milante R, Giessinger J, Foley-Peres K, Marcus C, Severson E, Duncan D, Sivakumar S, Ross JS, Desphande V, Ramkissoon SH, Vergilio JA, Louissaint A, Zukerberg LR, Williams EA. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma. Oncologist 2021;26:e1263-72. [PMID: 33904632 DOI: 10.1002/onco.13801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Furia S, Nannini N, Pascarella A, Breda C. Mediastinal Rosai-Dorfman Disease With Widespread Lesions: When Surgical Biopsy Is Needed. Ann Thorac Surg 2020;109:e45-7. [PMID: 31207246 DOI: 10.1016/j.athoracsur.2019.04.089] [Reference Citation Analysis]
53 Wang F, Cao X, Niu N, Zhang Y, Wang Y, Feng F, Jin Z. Multisystemic Imaging Findings in Chinese Patients With Erdheim-Chester Disease. American Journal of Roentgenology 2019;213:1179-86. [DOI: 10.2214/ajr.19.21523] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.7] [Reference Citation Analysis]
54 Kantardjiev V, Beshanska-Pedersen B, Obreshkova E. Yellow papules and nodules in an infant. JAAD Case Rep 2021;9:15-7. [PMID: 33598518 DOI: 10.1016/j.jdcr.2020.12.022] [Reference Citation Analysis]
55 Ziogas IA, Kakos CD, Wu WK, Montenovo MI, Matsuoka LK, Zarnegar-Lumley S, Alexopoulos SP. Liver Transplantation for Langerhans Cell Histiocytosis: A US Population-Based Analysis and Systematic Review of the Literature. Liver Transpl 2021;27:1181-90. [PMID: 33484600 DOI: 10.1002/lt.25995] [Reference Citation Analysis]
56 Cheng C, Chu W, Chang K, Chen J. Lymphoma-based therapy for refractory or relapsed Epstein–Barr virus–related hemophagocytic lymphohistiocytosis in children. Journal of the Formosan Medical Association 2022. [DOI: 10.1016/j.jfma.2022.01.009] [Reference Citation Analysis]
57 Sollier M, Halbron M, Donadieu J, Idbaih A, Cohen Aubart F, Vigouroux C, Auclair M, Bourron O, Bastin M, Béra G, Touraine P, Young J, Mosbah H, Hartemann A, Andreelli F, Amouyal C. Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis. Case Rep Endocrinol 2019;2019:2719364. [PMID: 31341684 DOI: 10.1155/2019/2719364] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
58 Pegoraro F, Papo M, Maniscalco V, Charlotte F, Haroche J, Vaglio A. Erdheim–Chester disease: a rapidly evolving disease model. Leukemia 2020;34:2840-57. [DOI: 10.1038/s41375-020-0944-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
59 Plemel DJA, Benson MD, Tong CM, Mahmood MN, Pollock TJ. Nonosseous Periocular Manifestations of Langerhans Cell Histiocytosis: A Case Report and Systematic Review. Ophthalmic Plast Reconstr Surg 2020. [PMID: 33315841 DOI: 10.1097/IOP.0000000000001906] [Reference Citation Analysis]
60 Brown NA, Elenitoba-Johnson KSJ. Clinical implications of oncogenic mutations in pulmonary Langerhans cell histiocytosis. Curr Opin Pulm Med 2018;24:281-6. [PMID: 29470255 DOI: 10.1097/MCP.0000000000000470] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
61 Mello RB, Vale ECSD. Necrobiotic xanthogranuloma associated with smoldering multiple myeloma: satisfactory response to cyclophosphamide, dexamethasone, and thalidomide. An Bras Dermatol 2019;94:337-40. [PMID: 31365665 DOI: 10.1590/abd1806-4841.20198500] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
62 Jacobsen E, Abla O, Visser J. Malignant Histiocytoses. In: Abla O, Janka G, editors. Histiocytic Disorders. Cham: Springer International Publishing; 2018. pp. 361-81. [DOI: 10.1007/978-3-319-59632-7_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
63 Cao XX, Duan MH, Zhao AL, Cai H, Chen J, Gao XM, Liu T, Cai HC, Zhang L, Sun J, Liang ZY, Zhou DB, Li J. Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis. Am J Hematol 2021. [PMID: 34797941 DOI: 10.1002/ajh.26412] [Reference Citation Analysis]
64 Kim JY, Shim HK, Kim MR. A Case of Extranodal Rosai-Dorfman Disease Presenting as an Isolated Mass on the Base of the Tongue in a 57-Year-old Woman. Am J Case Rep 2020;21:e925716. [PMID: 32776915 DOI: 10.12659/AJCR.925716] [Reference Citation Analysis]
65 Yoon D, Jang D, Byun HJ, Park CS, Park JH, Lee JH, Lee DY. A case of generalized xanthogranuloma with systemic involvement. JAAD Case Rep 2019;5:1097-100. [PMID: 31828195 DOI: 10.1016/j.jdcr.2019.09.018] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
66 Zanelli M, Zizzo M, Ascani S. Asymptomatic Infiltrated Erythematous Skin Patch on the Breast. JAMA Dermatol 2019;155:1420-1. [PMID: 31693054 DOI: 10.1001/jamadermatol.2019.3273] [Reference Citation Analysis]
67 Baker R, Liew JW, Simonson PD, Soma LA, Starkebaum G. Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab. Clin Rheumatol 2019;38:603-8. [PMID: 30535729 DOI: 10.1007/s10067-018-4387-5] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
68 Deshayes R, Eustache M, Moreau A, Péterlin P, Néel A, Masseau A, Bodet-Milin C, Hamidou M. [Systemic Rosai-Dorfman-Destombes disease associated with a myelodysplastic syndrome. Efficacy of hematologic treatment]. Rev Med Interne 2021;42:281-4. [PMID: 33485702 DOI: 10.1016/j.revmed.2021.01.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
69 Needs T, Lynch D. Unexpected aetiology of chronic thrombocytopaenia. J Clin Pathol 2020;73:609. [PMID: 32102802 DOI: 10.1136/jclinpath-2019-206289] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
70 Al-Ghawas MS, Ng T, Chen LYC. Confirmed Efficacy of Lenalidomide and Dexamethasone in Unresectable Cutaneous Facial Rosai-Dorfman-Destombes Disease. Mayo Clin Proc Innov Qual Outcomes 2019;3:94-6. [PMID: 30899913 DOI: 10.1016/j.mayocpiqo.2018.11.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
71 Igase M, Shousu K, Fujiki N, Sakurai M, Bonkobara M, Hwang CC, Coffey M, Noguchi S, Nemoto Y, Mizuno T. Anti-tumour activity of oncolytic reovirus against canine histiocytic sarcoma cells. Vet Comp Oncol 2019;17:184-93. [PMID: 30761736 DOI: 10.1111/vco.12468] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
72 Tang X, Guo X, Gao J, Sun JJ. X-linked chronic granulomatous disease misdiagnosed as non-Langerhans cell histiocytosis: A case report. Scand J Immunol 2021;93:e12948. [PMID: 32697334 DOI: 10.1111/sji.12948] [Reference Citation Analysis]
73 DeFelice DS, Srinivas ML, Wobker SE, Parr JB. Going Bone Deep: Osseous Rosai-Dorfman Disease in an Adult with Recurrent, Culture-Negative Osteomyelitis. Case Rep Infect Dis 2018;2018:6151738. [PMID: 29888015 DOI: 10.1155/2018/6151738] [Reference Citation Analysis]
74 Bonometti A, Sacco G, De Juli E, Invernizzi R, Venegoni L, Bagnoli F, Moltrasio C, Passoni E, Bellistri F, Bianchi P, Alaibac M, Paulli M, Berti E. Multisystem non‐arthropathic reticulohistiocytosis: problems and pitfalls in the differential diagnosis of multisystem non‐Langerhans‐cell histiocytoses. J Eur Acad Dermatol Venereol 2019;33:e195-8. [DOI: 10.1111/jdv.15461] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
75 Jheeta AS, Nayagam JS, Zen Y, Joshi D. A Case of Rosai-Dorfman Disease Mimicking Immunoglobulin G4-Related Autoimmune Pancreatitis. Pancreas 2021;50:e84-5. [PMID: 35041350 DOI: 10.1097/MPA.0000000000001945] [Reference Citation Analysis]
76 Ungari M, Caresana G, Tanzi G, Drera B, Frittoli MC, Gusolfino MD, Ferrero G, Varotti E, Manotti L, Trombatore M, Bertoni R. Congenital Unilesional Cutaneous Langerhans Cell Histiocytosis: A Case Report. Am J Dermatopathol 2021;43:e38-42. [PMID: 32769549 DOI: 10.1097/DAD.0000000000001770] [Reference Citation Analysis]
77 Hadchiti J, Kamar FG, Ghosn JA, Haidar M, Younes A, Obeid A, Haddad M, Farhat F, Chehade F. 18F-fluoro-2-deoxyglucose positron emission-computed tomography in a rare cutaneous form of Rosai-Dorfman disease: A case report. Mol Clin Oncol 2018;8:236-41. [PMID: 29435284 DOI: 10.3892/mco.2017.1507] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
78 Guerra Soares Brandão AA, Ramires Neder Abdo A, Lage LAPC, Fatobene G, Pereira J, Rocha V. Clinical, laboratory and genetic features of Erdheim-Chester disease patients: analysis of a retrospective cohort of two reference centers in Latin America. Hematology 2022;27:65-9. [PMID: 34957931 DOI: 10.1080/16078454.2021.2011547] [Reference Citation Analysis]
79 Rastogi A, Jaisingh K, Rajurkar K, Saran RK, Singh M, Baindur S, Singiri D, Gaonker T. Coexistent Rosai Dorfman disease and Langerhans cell histiocytosis in an Orbital mass: A Case Report. Eur J Ophthalmol 2022;:11206721221083727. [PMID: 35229680 DOI: 10.1177/11206721221083727] [Reference Citation Analysis]
80 Othman J, Bonar F, Brown W, Boyle R, Khoo TL. Multiply relapsed mixed histiocytosis in an adult responding to clofarabine after failure of cladribine. Leuk Lymphoma 2020;61:477-80. [PMID: 31483174 DOI: 10.1080/10428194.2019.1660976] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
81 Rafiei A, Wilk CM, Helbling PM, Myburgh R, Saito Y, Haralambieva E, Soldini D, Chakraborty R, Merad M, Allen CE, Nombela-Arrieta C, Manz MG. BRAFV 600E or mutant MAP2K1 human CD34+ cells establish Langerhans cell-like histiocytosis in immune-deficient mice. Blood Adv 2020;4:4912-7. [PMID: 33035332 DOI: 10.1182/bloodadvances.2020001926] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
82 Ranganathan S. Histiocytic proliferations. Seminars in Diagnostic Pathology 2016;33:396-409. [DOI: 10.1053/j.semdp.2016.08.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
83 Sezer H, Aygün MS, Armutlu A, Acar Ö, Falay FO, Yazici D, Deyneli O, Alagöl F. Erdheim-chester disease: Case report with testes involvement and review of literature. Urol Case Rep 2018;18:19-21. [PMID: 29686965 DOI: 10.1016/j.eucr.2018.02.007] [Reference Citation Analysis]
84 Bonometti A, Gliozzo J, Moltrasio C, Bagnoli F, Berti E. Cutaneous-group histiocytoses associated with myeloid malignancies: A systematic review of 102 cases. Australas J Dermatol 2021;62:e162-9. [PMID: 33125722 DOI: 10.1111/ajd.13491] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Shanmugam V, Craig JW, Hornick JL, Morgan EA, Pinkus GS, Pozdnyakova O. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations. American Journal of Surgical Pathology 2017;41:1390-6. [DOI: 10.1097/pas.0000000000000897] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 5.6] [Reference Citation Analysis]
86 Fraitag S. [Dermatopathology histoseminar. Case 3]. Ann Pathol 2018;38:223-9. [PMID: 30082024 DOI: 10.1016/j.annpat.2018.05.012] [Reference Citation Analysis]
87 Dasdelen S, Büschek F. Erdheim-Chester-Erkrankung – eine histiozytäre Multisystemerkrankung mit ungewöhnlicher Nierenbeteiligung. Internist 2020;61:969-79. [DOI: 10.1007/s00108-020-00849-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
88 Lee SM, Lim YT, Jang KM, Gu MJ, Lee JH, Lee JM. Hemophagocytic lymphohistiocytosis with recurrent Kikuchi-Fujimoto disease. Yeungnam Univ J Med 2021;38:245-50. [PMID: 33171575 DOI: 10.12701/yujm.2020.00654] [Reference Citation Analysis]
89 Zhou L, Liu Y, Wen Z, Yang S, Li M, Zhu Q, Qiu S, Gao Y, Wang H, Yuan Y, Zhang H, Chen C, Zeng W, Guan Z, Pan X. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome. J Cancer Res Clin Oncol 2020;146:3063-74. [PMID: 32617699 DOI: 10.1007/s00432-020-03301-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
90 Wang J, Wang Y, Li G, Wang C, Yu G, Sun Y. Rosai-Dorfman disease originating from nasal septal mucosa and presenting with nasal dorsum collapse: A case report with literature review. Ear Nose Throat J 2022;:1455613221079500. [PMID: 35171732 DOI: 10.1177/01455613221079500] [Reference Citation Analysis]
91 Bedran NR, Carlos R, de Andrade BAB, Bueno APS, Romañach MJ, Milito CB. Clinicopathological and Immunohistochemical Study of Head and Neck Langerhans Cell Histiocytosis from Latin America. Head Neck Pathol 2018;12:431-9. [PMID: 29164473 DOI: 10.1007/s12105-017-0867-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
92 Bonometti A, Passoni E, Finotto S, Berti E. Nail involvement in Langerhans cell histiocytosis and its association with multisystem presentation and lung involvement. Indian J Dermatol Venereol Leprol 2021;87:850-4. [PMID: 34491685 DOI: 10.25259/IJDVL_50_2021] [Reference Citation Analysis]
93 Voller LM, Totoraitis KE, Gaddis KJ, Pearson DR. Disseminated Langerhans cell histiocytosis in a 51-year-old man with cutaneous involvement and multiple endocrinopathies. JAAD Case Rep 2019;5:835-7. [PMID: 31646157 DOI: 10.1016/j.jdcr.2019.07.011] [Reference Citation Analysis]
94 Portuguese AJ, Long TH, Linenberger M. Necrobiotic Xanthogranuloma. Mayo Clin Proc 2021;96:2432-4. [PMID: 34481598 DOI: 10.1016/j.mayocp.2021.05.012] [Reference Citation Analysis]
95 Wang Y, Camelo-Piragua S, Abdullah A, Ibrahim M, Parmar HA. Neuroimaging features of CNS histiocytosis syndromes. Clin Imaging 2020;60:131-40. [PMID: 31874337 DOI: 10.1016/j.clinimag.2019.10.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
96 Kime A, Bréal C, Cottereau AS, Friedrich C, Decroocq J, Kaltenbach S, Lupo A, Copin MC, Pasmant E, Deschamps P, Emile JF, Bouscary D, Burroni B. Malignant histiocytosis with a Langerhans cell subtype: A report on the diagnostic and therapeutic challenge. Blood Cells Mol Dis 2021;92:102623. [PMID: 34751149 DOI: 10.1016/j.bcmd.2021.102623] [Reference Citation Analysis]
97 Paolino G, Cota C, Giona F, Donati P, Lora V, Moliterni E, Santopietro M, Calvieri S, Carbone A, Zalaudek I. The different dermoscopic features of the yellow background in Langerhans and non-Langerhans cells histiocytosis. Clin Exp Dermatol 2017;42:679-82. [PMID: 28543371 DOI: 10.1111/ced.13137] [Reference Citation Analysis]
98 Civit JJR, Godoy D, Conde A, Arencibia J, Medel R, Limeres MA, Miguel IS, Marín JD, Aguilar Y, Tresserra F, Medina F. Orbital histiocytosis with systemic involvement: A case with complex affiliations. Saudi J Ophthalmol 2020;34:319-23. [PMID: 34527883 DOI: 10.4103/1319-4534.322613] [Reference Citation Analysis]
99 Lamant L. [Dermatopathology histoseminar. Case 6]. Ann Pathol 2018;38:241-4. [PMID: 29980306 DOI: 10.1016/j.annpat.2018.05.008] [Reference Citation Analysis]
100 Chauhan S, Diwaker P, Singh A, Gogoi P, Arora VK. Cytological diagnosis of juvenile xanthogranuloma: A rare histiocytic disorder. Diagn Cytopathol 2020;48:66-70. [PMID: 31432610 DOI: 10.1002/dc.24310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
101 Olson NJ, Addante RR, de Abreu FB, Memoli VA. Central xanthoma of the jaw in association with Noonan syndrome. Hum Pathol 2018;82:202-5. [PMID: 29727697 DOI: 10.1016/j.humpath.2018.04.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
102 Neckel N, Lissat A, von Stackelberg A, Thieme N, Doueiri MS, Spors B, Beck-Broichsitter B, Heiland M, Raguse JD. Primary oral manifestation of Langerhans cell histiocytosis refractory to conventional therapy but susceptible to BRAF-specific treatment: a case report and review of the literature. Ther Adv Med Oncol 2019;11:1758835919878013. [PMID: 31666812 DOI: 10.1177/1758835919878013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
103 Roosta Y, Esfahani A, Vahedi A, Tarvirizadeh K, Asoubar S, Boroofeh B, Dinparast R, Behzadi F, Raeisi M, Hosseiniazar MM. Rosai-Dorfman disease presenting with solitary liver mass without lymphadenopathy: A case report. Clin Case Rep 2021;9:e04709. [PMID: 34466261 DOI: 10.1002/ccr3.4709] [Reference Citation Analysis]
104 Zhang Y, Liu J, Zhu J, Zhou X, Zhang K, Wang S, Ma W, Pan H, Wang R, Zhu H, Yao Y. Case Report: Rosai-Dorfman Disease Involving Sellar Region in a Pediatric Patient: A Case Report and Systematic Review of Literature. Front Med (Lausanne) 2020;7:613756. [PMID: 33330575 DOI: 10.3389/fmed.2020.613756] [Reference Citation Analysis]
105 Chung KB, Hwang J, Kim D. Profiling immune network in regressing histiocytic dermatosis: a case report. Journal of Dermatological Science 2022. [DOI: 10.1016/j.jdermsci.2022.02.002] [Reference Citation Analysis]
106 Ko CJ, Atzmony L, Lim Y, Mcniff JM, Craiglow BG, Antaya RJ, Choate KA. Review of genodermatoses with characteristic histopathology and potential diagnostic delay. J Cutan Pathol 2019;46:756-65. [DOI: 10.1111/cup.13520] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
107 Mavrogenis AF, Igoumenou VG, Antoniadou T, Megaloikonomos PD, Agrogiannis G, Foukas P, Papageorgiou SG. Rare diseases of bone: Erdheim-Chester and Rosai-Dorfman non-Langerhans cell histiocytoses. EFORT Open Rev 2018;3:381-90. [PMID: 30034819 DOI: 10.1302/2058-5241.3.170047] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
108 Vizcaino MA, Eberhart CG, Rodriguez FJ. Hemophagocytic Lymphohistiocytosis in Adults with Intraocular Involvement: Clinicopathologic Features of 3 Cases. Ocul Oncol Pathol 2017;4:1-11. [PMID: 29344491 DOI: 10.1159/000475551] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
109 Gao DK, Salomonis N, Henderlight M, Woods C, Thakkar K, Grom AA, Thornton S, Jordan MB, Wikenheiser-Brokamp KA, Schulert GS. IFN-γ is essential for alveolar macrophage driven pulmonary inflammation in macrophage activation syndrome. JCI Insight 2021:147593. [PMID: 34314387 DOI: 10.1172/jci.insight.147593] [Reference Citation Analysis]
110 Auerbach A, Schmieg JJ, Aguilera NS. Pediatric Lymphoid and Histiocytic Lesions in the Head and Neck. Head Neck Pathol 2021;15:41-58. [PMID: 33723759 DOI: 10.1007/s12105-020-01257-6] [Reference Citation Analysis]
111 Albano D, Bosio G, Giubbini R, Bertagna F. Role of 18F-FDG PET/CT in patients affected by Langerhans cell histiocytosis. Jpn J Radiol. 2017;35:574-583. [PMID: 28748503 DOI: 10.1007/s11604-017-0668-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.6] [Reference Citation Analysis]
112 Fu WJ, Du J, Lu J, Wang LZ, Yang JM, He MX, Hu XX. [Rosai-Dorfman disease: a clinicopathologic analysis and whole exome sequencing in 23 cases]. Zhonghua Xue Ye Xue Za Zhi 2019;40:656-61. [PMID: 31495132 DOI: 10.3760/cma.j.issn.0253-2727.2019.08.006] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Bishnoi A, De D, Khullar G, Parsad D, Handa S, Vishwajeet V, Saikia UN, Prakash G. Hypopigmented and acneiform lesions: An unusual initial presentation of adult-onset multisystem Langerhans cell histiocytosis. Indian J Dermatol Venereol Leprol 2018;84:621-6. [PMID: 30106015 DOI: 10.4103/ijdvl.IJDVL_639_17] [Reference Citation Analysis]
114 Techavichit P, Sosothikul D, Chaichana T, Teerapakpinyo C, Thorner PS, Shuangshoti S. BRAF V600E mutation in pediatric intracranial and cranial juvenile xanthogranuloma. Hum Pathol 2017;69:118-22. [PMID: 28504206 DOI: 10.1016/j.humpath.2017.04.026] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 4.2] [Reference Citation Analysis]
115 Wang DS, Lu MY, Yang YL, Lin DT, Lin KH, Chang HH, Jou ST. Clinical outcomes of childhood Langerhans cell histiocytosis in Taiwan: A single-center, 20-year experience. J Formos Med Assoc 2021;120:594-601. [PMID: 32741735 DOI: 10.1016/j.jfma.2019.12.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
116 Stalder G, Ribi C, Duchosal MA. [Hemophagocytic Lymphohistiocytosis]. Praxis (Bern 1994) 2018;107:902-11. [PMID: 30086687 DOI: 10.1024/1661-8157/a003045] [Reference Citation Analysis]
117 Bansal AG, Oudsema R, Masseaux JA, Rosenberg HK. US of Pediatric Superficial Masses of the Head and Neck. RadioGraphics 2018;38:1239-63. [DOI: 10.1148/rg.2018170165] [Cited by in Crossref: 37] [Cited by in F6Publishing: 23] [Article Influence: 9.3] [Reference Citation Analysis]
118 Gawdzik A, Ziarkiewicz-Wróblewska B, Chlebicka I, Jankowska-Konsur A, Szepietowski JC, Maj J. Cutaneous Rosai-Dorfman Disease: A Treatment Challenge. Dermatol Ther (Heidelb) 2021;11:1443-8. [PMID: 34143402 DOI: 10.1007/s13555-021-00557-1] [Reference Citation Analysis]
119 Montalvo N, Lara-Endara J, Redrobán L, Leiva M, Armijos C, Russo L. Primary splenic histiocytic sarcoma associated with hemophagocytic lymphohistiocytosis: A case report and review of literature of next-generation sequencing involving FLT3, NOTCH2, and KMT2A mutations. Cancer Rep (Hoboken) 2021;:e1496. [PMID: 34292677 DOI: 10.1002/cnr2.1496] [Reference Citation Analysis]
120 Westenend PJ, Akkers RC, Katier N, van Bommel EFH. Erdheim Chester disease presenting as sclerosing mesenteritis. J Hematopathol 2021;14:87-8. [DOI: 10.1007/s12308-020-00438-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
121 El-arab KK, Luedke AI, Julian BT, Ferrauiola J, Miller FR, Wang HT. Langerhans Cell Histiocytosis in an Adult: A Discussion of Epidemiology and Treatment Options. Journal of Craniofacial Surgery 2020;31:e70-3. [DOI: 10.1097/scs.0000000000005925] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
122 Zanelli M, Ragazzi M, Marchetti G, Bisagni A, Principi M, Fanni D, Froio E, Serra S, Zanetti E, De Marco L, Giangaspero F, Ascani S. Primary histiocytic sarcoma presenting as diffuse leptomeningeal disease: Case description and review of the literature. Neuropathology 2017;37:517-25. [PMID: 28548244 DOI: 10.1111/neup.12390] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
123 Papo M, Emile J, Maciel TT, Bay P, Baber A, Hermine O, Amoura Z, Haroche J. Erdheim-Chester Disease: a Concise Review. Curr Rheumatol Rep 2019;21. [DOI: 10.1007/s11926-019-0865-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
124 Mitsui Y, Ogawa K, Mashiba K, Fukumoto T, Asada H. Case of S100-positive benign cephalic histiocytosis involving monocyte/macrophage lineage marker expression. J Dermatol 2018;45:e344-5. [PMID: 29766556 DOI: 10.1111/1346-8138.14475] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
125 Parks NE, Goyal G, Go RS, Mandrekar J, Tobin WO. Neuroradiologic manifestations of Erdheim-Chester disease. Neurol Clin Pract 2018;8:15-20. [PMID: 29517068 DOI: 10.1212/CPJ.0000000000000422] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 5.8] [Reference Citation Analysis]
126 Cavalli G, Dagna L, Biavasco R, Villa A, Doglioni C, Ferrero E, Ferrarini M. Erdheim-Chester disease: An in vivo human model of Mϕ activation at the crossroad between chronic inflammation and cancer. J Leukoc Biol 2020;108:591-9. [PMID: 32056262 DOI: 10.1002/JLB.3MR0120-203RR] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
127 Hédan B, Rault M, Abadie J, Ulvé R, Botherel N, Devauchelle P, Copie-Bergman C, Cadieu E, Parrens M, Alten J, Zalcman EL, Cario G, Damaj G, Mokhtari K, Le Loarer F, Coulomb-Lhermine A, Derrien T, Hitte C, Bachelot L, Breen M, Gilot D, Blay JY, Donadieu J, André C. PTPN11 mutations in canine and human disseminated histiocytic sarcoma. Int J Cancer 2020;147:1657-65. [PMID: 32212266 DOI: 10.1002/ijc.32991] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
128 Kobayashi KR, Hajiyev Y, Fuller MY, Orman G, Lambert EM. Presentation of External Ear Rosai-Dorfman Disease With Laryngeal Involvement. Ear Nose Throat J 2021;:1455613211016704. [PMID: 33973483 DOI: 10.1177/01455613211016704] [Reference Citation Analysis]
129 Obert J, Vercellino L, Van Der Gucht A, de Margerie-mellon C, Bugnet E, Chevret S, Lorillon G, Tazi A. 18F-fluorodeoxyglucose positron emission tomography-computed tomography in the management of adult multisystem Langerhans cell histiocytosis. Eur J Nucl Med Mol Imaging 2017;44:598-610. [DOI: 10.1007/s00259-016-3521-3] [Cited by in Crossref: 29] [Cited by in F6Publishing: 20] [Article Influence: 4.8] [Reference Citation Analysis]
130 Papo M, Cohen-Aubart F, Trefond L, Bauvois A, Amoura Z, Emile JF, Haroche J. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders. Curr Oncol Rep. 2019;21:62. [PMID: 31115724 DOI: 10.1007/s11912-019-0810-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
131 Chasset F, Haroche J. Cutaneous manifestations of paediatric Erdheim–Chester disease, a histiocytosis of the ‘L’ group. Br J Dermatol 2018;178:31-2. [DOI: 10.1111/bjd.15860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
132 Huynh KN, Nguyen BD. Histiocytosis and Neoplasms of Macrophage-Dendritic Cell Lineages: Multimodality Imaging with Emphasis on PET/CT. Radiographics 2021;41:576-94. [PMID: 33606566 DOI: 10.1148/rg.2021200096] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
133 Buján MM, Sánchez La Rosa C, Galluzzo Mutti ML, Braier J, Diamond EL. Progressive nodular histiocytosis in a 9‐year‐old boy treated with cobimetinib. Pediatric Dermatology. [DOI: 10.1111/pde.14887] [Reference Citation Analysis]
134 Vithran DTA, Wang JZ, Xiang F, Wen J, Xiao S, Tang WZ, Chen Q. Osseous Rosai-Dorfman disease of tibia in children: A case report. World J Clin Cases 2021; 9(6): 1416-1423 [PMID: 33644210 DOI: 10.12998/wjcc.v9.i6.1416] [Reference Citation Analysis]
135 Xu XJ, Tang YM. Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children. World J Pediatr 2020;16:333-40. [PMID: 31506890 DOI: 10.1007/s12519-019-00299-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
136 Zhu Q, Liang Y, Fan Z, Liu Y, Zhou C, Zhang H, Li T, Zhou Y, Yang J, Wang L. Management of central nervous system Rosai-Dorfman disease: A single center treatment experience. Journal of Clinical Neuroscience 2022;99:275-81. [DOI: 10.1016/j.jocn.2022.03.028] [Reference Citation Analysis]
137 Kim DY, Kim PH, Jung AY, Choi JH, Cho YA, Yoon HM, Lee JS. Neoplastic Etiology and Natural Course of Pituitary Stalk Thickening: A Systematic Review and Meta-analysis. J Clin Endocrinol Metab 2021:dgab732. [PMID: 34614160 DOI: 10.1210/clinem/dgab732] [Reference Citation Analysis]
138 Yavropoulou MP, Tsoli M, Kaltsas G. Neuroendocrine manifestations of Langerhans cell histiocytosis. Handb Clin Neurol 2021;181:127-35. [PMID: 34238452 DOI: 10.1016/B978-0-12-820683-6.00009-9] [Reference Citation Analysis]
139 Baker JC, Kyriakos M, McDonald DJ, Rubin DA. Primary Rosai-Dorfman disease of the femur. Skeletal Radiol 2017;46:129-35. [PMID: 27785544 DOI: 10.1007/s00256-016-2515-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
140 Baky F, Milbrandt TA, Arndt C, Houdek MT, Larson AN. Vertebra Plana in Children May Result from Etiologies Other Than Eosinophilic Granuloma. Clin Orthop Relat Res 2020;478:2367-74. [PMID: 32667754 DOI: 10.1097/CORR.0000000000001409] [Reference Citation Analysis]
141 Pegoraro F, Maniscalco V, Peyronel F, Westenend PJ, Hendriksz TR, Roperto RM, Palumbo AA, Sieni E, Romagnani P, van Bommel EFH, Vaglio A. Long-term follow-up of mTOR inhibition for Erdheim-Chester disease. Blood 2020;135:1994-7. [PMID: 32299103 DOI: 10.1182/blood.2019004478] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
142 Bezerra Lima L, Alves Sobreira-Neto M, Braga-Neto P, Ribeiro Nóbrega P. Isolated central nervous system Rosai-Dorfman disease and breast cancer: an unusual presentation. Int J Neurosci 2019;129:393-6. [PMID: 30296195 DOI: 10.1080/00207454.2018.1533823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
143 Egeler RM, Katewa S, Leenen PJ, Beverley P, Collin M, Ginhoux F, Arceci RJ, Rollins BJ; for the Steering Committee of the Nikolas Symposium. Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In memory of Bob Arceci: Egeler et al. Pediatr Blood Cancer 2016;63:1704-12. [DOI: 10.1002/pbc.26104] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 5.2] [Reference Citation Analysis]
144 Monmany J, Granell E, López L, Domingo P. Resolved heart tamponade and controlled exophthalmos, facial pain and diabetes insipidus due to Erdheim-Chester disease. BMJ Case Rep 2018;2018:bcr-2018-225224. [PMID: 30337283 DOI: 10.1136/bcr-2018-225224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
145 Luder C, Nordmann T, Ramelyte E, Mühleisen B, Kerl K, Guenova E, Dummer R. Histiocytosis - cutaneous manifestations of hematopoietic neoplasm and non-neoplastic histiocytic proliferations. J Eur Acad Dermatol Venereol 2018;32:926-34. [DOI: 10.1111/jdv.14794] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
146 Buckley K, Baiocchi RA, Kaffenberger B, Chung CG. Cutaneous involvement of Erdheim-Chester disease in a patient with Burkitt lymphoma. J Cutan Pathol 2021;48:928-31. [PMID: 33599338 DOI: 10.1111/cup.13988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
147 Badlissi F, Pihan GA, Corominas H. Rosai-Dorfman disease: Ultrasonography and histopathology study of a soft tissue mass in the forearm. Reumatol Clin (Engl Ed) 2020;16:174-6. [PMID: 29606510 DOI: 10.1016/j.reuma.2018.02.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
148 Katayama S, Ota M. An Uncommon Pediatric Rash: Langerhans Cell Histiocytosis. J Pediatr 2021:S0022-3476(21)01169-0. [PMID: 34890586 DOI: 10.1016/j.jpeds.2021.11.071] [Reference Citation Analysis]
149 Suh JK, Kang S, Kim H, Im HJ, Koh KN. Recent advances in the understanding of the molecular pathogenesis and targeted therapy options in Langerhans cell histiocytosis. Blood Res 2021;56:S65-9. [PMID: 33935037 DOI: 10.5045/br.2021.2021013] [Reference Citation Analysis]
150 Maeda M, Morimoto A, Shioda Y, Asano T, Koga Y, Nakazawa Y, Kanegane H, Kudo K, Ohga S, Ishii E; Histiocytosis Study Group of the Japanese Society of Pediatric Hematology/Oncology. Long-term outcomes of children with extracutaneous juvenile xanthogranulomas in Japan. Pediatr Blood Cancer 2020;67:e28381. [PMID: 32383820 DOI: 10.1002/pbc.28381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
151 Al Mugairi A, Al Turki S, Salama H, Al Ahmadi K, Abuelgasim KA, Damlaj M. Isolated Bone Marrow Non-Langerhans Cell Histiocytosis Preceding RUNX1-Mutated Acute Myeloid Leukemia: Case Report and Literature Review. Am J Clin Pathol 2019;151:638-46. [PMID: 30989185 DOI: 10.1093/ajcp/aqz018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
152 Huang Y, Zhang Z, Zhu L, Chen Y. Treatment of Progressive Nodular Histiocytosis With Baricitinib. JAMA Dermatol 2022. [PMID: 35044417 DOI: 10.1001/jamadermatol.2021.5579] [Reference Citation Analysis]
153 Afzal A, Asadbeigi SN, Farooque U, Mather C, Khan S. Histiocytic sarcoma arising from a lymph node: a diagnostic conundrum. Int Cancer Conf J 2021;10:244-7. [PMID: 34221840 DOI: 10.1007/s13691-021-00489-9] [Reference Citation Analysis]
154 Papavasiliou K, Bintoudi A, Vlahodimos A, Tsiridis E, Hytiroglou P, Tsitouridis I, Sayegh F. Localized Chronic Form of Langerhans Cell Histiocytosis in the Femur of a 16-Year-Old Male Successfully Treated with Radiofrequency Ablation. Case Rep Oncol Med 2020;2020:4052034. [PMID: 32612861 DOI: 10.1155/2020/4052034] [Reference Citation Analysis]
155 Dellatorre G, Miqueloto JK. Necrobiotic Xanthogranuloma. JAMA Dermatol 2020;156:696. [PMID: 32374351 DOI: 10.1001/jamadermatol.2020.0897] [Reference Citation Analysis]
156 Saade-lemus S, Teixeira SR, Vossough A, Servaes S, States LJ. Emerging Roles of PET/MR in the Pediatric Hospital. PET Clinics 2020;15:253-69. [DOI: 10.1016/j.cpet.2020.03.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Traidl S, Angela Y, Wedi B, Kapp A, Werfel T, Schacht V. Langerhans cell histiocytosis mimicking prurigo nodularis. J Eur Acad Dermatol Venereol 2021;35:e259-61. [PMID: 33040393 DOI: 10.1111/jdv.16991] [Reference Citation Analysis]
158 Egan C, Nicolae A, Lack J, Chung HJ, Skarshaug S, Pham TA, Navarro W, Abdullaev Z, Aguilera NS, Xi L, Pack S, Pittaluga S, Jaffe ES, Raffeld M. Genomic profiling of primary histiocytic sarcoma reveals two molecular subgroups. Haematologica 2020;105:951-60. [PMID: 31439678 DOI: 10.3324/haematol.2019.230375] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 6.7] [Reference Citation Analysis]
159 Gioco G, Rupe C, Basco A, Contaldo M, Gallenzi P, Lajolo C. Oral juvenile xanthogranuloma: An unusual presentation in an adult patient and a systematic analysis of published cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2021:S2212-4403(21)00673-8. [PMID: 34736900 DOI: 10.1016/j.oooo.2021.09.015] [Reference Citation Analysis]
160 Wang D, Chen X, Wei A, Zhou C, Zhang X, Ma H, Lian H, Zhang L, Zhang Q, Huang X, Wang C, Yang Y, Liu W, Wang T, Li Z, Cui L, Zhang R. Clinical features and treatment outcomes of pediatric Langerhans cell histiocytosis with macrophage activation syndrome-hemophagocytic lymphohistiocytosis. Orphanet J Rare Dis 2022;17. [DOI: 10.1186/s13023-022-02276-y] [Reference Citation Analysis]
161 Hannah-shmouni F, Boyd L, Papadakis GZ, Tirosh A, Gahl WA, Estrada-veras JI, O'brien K. Association of BRAF V600E with Hypothalamic-Pituitary-Adrenal Axis Involvement in Erdheim-Chester Disease. Endocrine and Metabolic Science 2020;1:100051. [DOI: 10.1016/j.endmts.2020.100051] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
162 Hattori-Murakami M, Tanaka R, Yamamoto T, Hayashi H, Nishimura H, Fujimoto W. Benign cephalic histiocytosis: A case with infiltration of CD1a-positive langerin-negative cells. J Dermatol 2018;45:e181-2. [PMID: 29430698 DOI: 10.1111/1346-8138.14256] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
163 Lee M, Ryu KH, Baek HJ, Moon JI, Yoon S, An HJ, Nam IC. Rosai-Dorfman disease with infiltration of IgG4-bearing plasma cells presenting as laryngeal-nasal masses and cervical lymphadenopathy: A case report. Medicine (Baltimore) 2021;100:e25165. [PMID: 33761691 DOI: 10.1097/MD.0000000000025165] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
164 Freitas JG, Jorge A, Rei D, Graça J. Ninety-year-old man with hypereosinophilia, lymphadenopathies and pruritus. BMJ Case Rep 2018;2018:bcr-2017-222306. [PMID: 29326339 DOI: 10.1136/bcr-2017-222306] [Reference Citation Analysis]
165 Kashima J, Yoshida M, Jimbo K, Izutsu K, Ushiku T, Yonemori K, Yoshida A. ALK-positive Histiocytosis of the Breast: A Clinicopathologic Study Highlighting Spindle Cell Histology. Am J Surg Pathol 2021;45:347-55. [PMID: 32826530 DOI: 10.1097/PAS.0000000000001567] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
166 Toya T, Ogura M, Toyama K, Yoshimi A, Shinozaki-Ushiku A, Honda A, Honda K, Hosoya N, Murakami Y, Kawashima H, Nannya Y, Arai S, Nakamura F, Shinoda Y, Nangaku M, Miyagawa K, Fukayama M, Moriya-Saito A, Katayama I, Ogura T, Kurokawa M. Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan. Haematologica 2018;103:1815-24. [PMID: 29976744 DOI: 10.3324/haematol.2018.190728] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
167 Alzahem T, Maktabi A, Alkatan H. Solitary reticulohistiocytoma: a rare ocular surface mass. Can J Ophthalmol 2021;56:e64-6. [PMID: 32890466 DOI: 10.1016/j.jcjo.2020.08.001] [Reference Citation Analysis]
168 Liao X, Thorson JA, Hughes T, Nguyen JC, Wang HY, Lin GY. Erdheim-Chester disease with novel gene mutations discovered as an incidental finding in explanted liver of a patient with hepatitis C cirrhosis: A case report and literature review. Pathol Res Pract 2016;212:849-54. [PMID: 27445228 DOI: 10.1016/j.prp.2016.07.001] [Reference Citation Analysis]
169 Adens A, Landy P, Terriou L, Baillet C, Beron A, Lambert M, Launay D, Huglo D. [Usefulness of nuclear medicine in Erdheim-Chester disease: A Lille experience]. Rev Med Interne 2017;38:235-42. [PMID: 28268124 DOI: 10.1016/j.revmed.2016.10.386] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
170 Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, Durham BH, Braier J, Charlotte F, Donadieu J, Cohen-Aubart F, Rodriguez-Galindo C, Allen C, Whitlock JA, Weitzman S, McClain KL, Haroche J, Diamond EL. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease. Blood. 2018;131:2877-2890. [PMID: 29720485 DOI: 10.1182/blood-2018-03-839753] [Cited by in Crossref: 124] [Cited by in F6Publishing: 103] [Article Influence: 31.0] [Reference Citation Analysis]
171 Allen CE, Beverley PCL, Collin M, Diamond EL, Egeler RM, Ginhoux F, Glass C, Minkov M, Rollins BJ, van Halteren A. The coming of age of Langerhans cell histiocytosis. Nat Immunol 2020;21:1-7. [DOI: 10.1038/s41590-019-0558-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
172 Nordmann TM, Juengling FD, Recher M, Berger CT, Kalbermatten D, Wicki A, Paasinen-Sohns A, Cathomas G, Tzankov A, Daikeler T. Trametinib after disease reactivation under dabrafenib in Erdheim-Chester disease with both BRAF and KRAS mutations. Blood 2017;129:879-82. [PMID: 27940476 DOI: 10.1182/blood-2016-09-740217] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
173 Dufour J, Mathon B, Touat M, Hoang-Xuan K, Mokhtari K, Idbaih A. BRAF mutation in overlapping form of Erdheim-Chester and Rosai Dorfman diseases: a unique case restricted to the central nervous system. Rev Neurol (Paris) 2021;177:708-10. [PMID: 33478735 DOI: 10.1016/j.neurol.2020.09.010] [Reference Citation Analysis]
174 Sampedro-Ruiz R, Martos-Cabrera L, Fraga-Fernández J, Aragüés M, Chicharro P. Multiple adult xanthogranuloma with upper airway involvement. Int J Dermatol 2021;60:e317-9. [PMID: 33560521 DOI: 10.1111/ijd.15453] [Reference Citation Analysis]
175 Villatoro-Villar M, Bold MS, Warrington KJ, Crowson CS, Goyal G, Shah M, Go RS, Koster MJ. Arterial involvement in Erdheim-Chester disease: A retrospective cohort study. Medicine (Baltimore) 2018;97:e13452. [PMID: 30544428 DOI: 10.1097/MD.0000000000013452] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
176 Silva Díaz E, Vázquez Fernández B, Monteagudo Castro C, Martín Hernández J. Benign Cephalic Histiocytosis Mimicking Mastocytosis. Actas Dermo-Sifiliográficas (English Edition) 2021. [DOI: 10.1016/j.adengl.2021.11.037] [Reference Citation Analysis]
177 He T, Cui L, Niu N, Wang F, Miao H, Zhao H, Gao X, Liu C, Yu F, Jiang Y, Wang O, Li M, Xing X, Zhou D, Li J, Cao X, Xia W. Bone mineral density and bone microarchitecture in a cohort of patients with Erdheim-Chester Disease. Orphanet J Rare Dis 2020;15:236. [PMID: 32887616 DOI: 10.1186/s13023-020-01518-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
178 Oliveira CC, Rocha JTQ, Silva GF, Biglia B, Gaiolla RD, Niero-Melo L, Domingues MAC. Would you think of histiocytic sarcoma in this fine-needle aspiration? Ann Hematol 2018;97:2257-9. [PMID: 29728735 DOI: 10.1007/s00277-018-3355-0] [Reference Citation Analysis]
179 Branco B, Comont T, Ysebaert L, Picard M, Laurent C, Oberic L. Targeted therapy of BRAF V600E-mutant histiocytic sarcoma: A case report and review of the literature. Eur J Haematol 2019;103:444-8. [PMID: 31376203 DOI: 10.1111/ejh.13303] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
180 Ben Nacef I, Mekni S, Mhedhebi C, Riahi I, Rojbi I, Nadia M, Khiari K. Langerhans Cell Histiocytosis of the Thyroid Leading to the Diagnosis of a Disseminated Form. Case Rep Endocrinol 2020;2020:6284764. [PMID: 32257462 DOI: 10.1155/2020/6284764] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
181 Dominguez-Santas M, Carretero-Barrio I, Suarez-Valle A, Diaz-Guimaraens B, Garcia-Cosio M, Ballester-Martínez A, Moreno-Garcia Del Real C. When histiocytoses are part of an ominous tetrad. Australas J Dermatol 2021;62:e485-7. [PMID: 34156706 DOI: 10.1111/ajd.13653] [Reference Citation Analysis]
182 Starkebaum G, Hendrie P. Erdheim-Chester disease. Best Pract Res Clin Rheumatol 2020;34:101510. [PMID: 32305313 DOI: 10.1016/j.berh.2020.101510] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
183 Kemps PG, Hebeda KM, Pals ST, Verdijk RM, Lam KH, Bruggink AH, de Lil HS, Ruiterkamp B, de Heer K, van Laar JA, Valk PJ, Mutsaers P, Levin MD, Hogendoorn PC, van Halteren AG. Spectrum of histiocytic neoplasms associated with diverse haematological malignancies bearing the same oncogenic mutation. J Pathol Clin Res 2021;7:10-26. [PMID: 32852896 DOI: 10.1002/cjp2.177] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
184 Satpathy AT, Brown RA, Gomulia E, Briseño CG, Mumbach MR, Pan Z, Murphy KM, Natkunam Y, Chang HY, Kim J. Expression of the transcription factor ZBTB46 distinguishes human histiocytic disorders of classical dendritic cell origin. Mod Pathol 2018;31:1479-86. [PMID: 29743654 DOI: 10.1038/s41379-018-0052-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
185 Bonometti A; for Associazione Italiana Ricerca Istiocitosi AIRI ONLUS. The triptych of mixed histiocytosis: a systematic review of 105 cases and proposed clinical classification. Leuk Lymphoma 2021;62:32-44. [PMID: 32969291 DOI: 10.1080/10428194.2020.1824070] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
186 Razanamahery J, Humbert S, Weil-Verhoeven D, Emile JF, Vuitton L, Magy-Bertrand N. Refractory Inflammatory Bowel Disease Associated With Sclerosing Cholangitis, Diabetes Insipidus, and Myeloid Neoplasm: Langerhans Cell Histiocytosis Was Hiding Since the Beginning. Inflamm Bowel Dis 2020;26:e85-6. [PMID: 32530029 DOI: 10.1093/ibd/izaa129] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
187 Pestronk A, Sinha N, Alhumayyd Z, Ly C, Schmidt R, Bucelli R. Immune myopathy with large histiocyte-related myofiber necrosis. Neurology 2019;92:e1763-72. [PMID: 30894448 DOI: 10.1212/WNL.0000000000007260] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
188 Horne A, Wickström R, Jordan MB, Yeh EA, Naqvi A, Henter JI, Janka G. How to Treat Involvement of the Central Nervous System in Hemophagocytic Lymphohistiocytosis? Curr Treat Options Neurol 2017;19:3. [PMID: 28155064 DOI: 10.1007/s11940-017-0439-4] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 9.2] [Reference Citation Analysis]
189 Cohen Aubart F, Haroche J, Emile JF, Charlotte F, Barete S, Schleinitz N, Donadieu J, Amoura Z. [Rosai-Dorfman disease: Diagnosis and therapeutic challenges]. Rev Med Interne 2018;39:635-40. [PMID: 29501513 DOI: 10.1016/j.revmed.2018.02.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
190 Yoon HS. A Recent Update on Histiocytic Disorder in Children: Focus on Diagnosis and Treatment. Clin Pediatr Hematol Oncol 2020;27:32-42. [DOI: 10.15264/cpho.2020.27.1.32] [Reference Citation Analysis]
191 Goyal G, Heaney ML, Collin M, Cohen-Aubart F, Vaglio A, Durham BH, Hershkovitz-Rokah O, Girschikofsky M, Jacobsen ED, Toyama K, Goodman AM, Hendrie P, Cao XX, Estrada-Veras JI, Shpilberg O, Abdo A, Kurokawa M, Dagna L, McClain KL, Mazor RD, Picarsic J, Janku F, Go RS, Haroche J, Diamond EL. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 2020;135:1929-45. [PMID: 32187362 DOI: 10.1182/blood.2019003507] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 40.0] [Reference Citation Analysis]
192 Chava VK, Bhanu VU. Adult multifocal Langerhan's cell histiocytosis involving periodontal tissues. J Indian Soc Periodontol 2021;25:166-70. [PMID: 33888951 DOI: 10.4103/jisp.jisp_22_20] [Reference Citation Analysis]
193 Ismayilov R, Aliyev A, Aliyev A, Hasanov I. Langerhans Cell Histiocytosis of Thyroid Gland in a Child: A Case Report and Literature Review. Eurasian J Med 2021;53:148-51. [PMID: 34177300 DOI: 10.5152/eurasianjmed.2021.20144] [Reference Citation Analysis]
194 AbdullGaffar B, Awadhi F. Oral manifestations of Langerhans cell histiocytosis with unusual histomorphologic features. Ann Diagn Pathol 2020;47:151536. [PMID: 32454442 DOI: 10.1016/j.anndiagpath.2020.151536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
195 Kobayashi M, Ando S, Kawamata T, Makiyama J, Yokoyama K, Imai Y, Tojo A. Clinical features and outcomes of adult Langerhans cell histiocytosis: a single-center experience. Int J Hematol 2020;112:185-92. [PMID: 32514929 DOI: 10.1007/s12185-020-02892-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
196 Bonometti A, Berti E; for Associazione Italiana Ricerca Istiocitosi ONLUS. Reticulohistiocytoses: a revision of the full spectrum. J Eur Acad Dermatol Venereol 2020;34:1684-94. [PMID: 31955466 DOI: 10.1111/jdv.16214] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
197 Deckers J, Hammad H, Hoste E. Langerhans Cells: Sensing the Environment in Health and Disease. Front Immunol 2018;9:93. [PMID: 29449841 DOI: 10.3389/fimmu.2018.00093] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 18.3] [Reference Citation Analysis]
198 Light J, Retrouvey M, Conran RM. Educational Case: Langerhans cell histiocytosis. Academic Pathology 2022;9:100018. [DOI: 10.1016/j.acpath.2022.100018] [Reference Citation Analysis]
199 Pyle T, Heymann WR. Multiple red-brown nodules and plaques on the face, trunk, and bilateral elbows. Int J Dermatol 2018;57:911-2. [PMID: 29806127 DOI: 10.1111/ijd.14054] [Reference Citation Analysis]
200 Holst JM, Enemark MB, Plesner TL, Pedersen MB, Ludvigsen M, d'Amore F. Coexisting BRAF-Mutated Langerhans Cell Histiocytosis and Primary Myelofibrosis with Shared JAK2 Mutation. Case Rep Hematol 2021;2021:6623706. [PMID: 33953993 DOI: 10.1155/2021/6623706] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
201 Nikpanah M, Kim L, Mirmomen SM, Symons R, Papageorgiou I, Gahl WA, O’brien K, Estrada-veras JI, Malayeri AA. Abdominal involvement in Erdheim-Chester disease (ECD): MRI and CT imaging findings and their association with BRAFV600E mutation. Eur Radiol 2018;28:3751-9. [DOI: 10.1007/s00330-018-5326-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
202 Medina MÁ, Meyer W, Echeverri C, Builes N. Langerhans cell histiocytosis: Case report and literature review. Biomedica 2021;41:396-402. [PMID: 34559487 DOI: 10.7705/biomedica.5430] [Reference Citation Analysis]
203 Hipólito LN, Mendoza‐cembranos MD, Villaescusa MT, Jo‐velasco M, Requena L, Alegría‐landa V. Langerhans cell histiocytosis and multiple reticulohistiocytomas in a patient with TAR syndrome: An association not previously described. J Cutan Pathol 2019;46:609-12. [DOI: 10.1111/cup.13483] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
204 Yang Y, Wang D, Li N, Ma H, Lian H, Cui L, Zhang Q, Zhao X, Zhang L, Zhao Y, Wang C, Zhang L, Wang T, Li Z, Zhang R. Improvement in Pituitary Imaging After Targeted Therapy in Three Children with BRAF-Mutated Langerhans Cell Histiocytosis with Pituitary Involvement. Onco Targets Ther 2020;13:12357-63. [PMID: 33293828 DOI: 10.2147/OTT.S279093] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
205 Tummidi S, Singh HK, Reddy PA, Sindhura M, Kosaraju N, Shankaralingappa A, Kumar NP. ROSE in Rosai-Dorfman-Destombes (RDD) disease: a cytological diagnosis. Eur J Med Res 2021;26:34. [PMID: 33849657 DOI: 10.1186/s40001-021-00505-x] [Reference Citation Analysis]
206 Sanchez-Petitto G, Duke TC, Swaby M, Aisenberg GM. Juvenile xanthogranuloma: A herald to the diagnosis of Erdheim-Chester disease in an adult with acute leukemia. J Cutan Pathol 2018;45:914-7. [PMID: 30117175 DOI: 10.1111/cup.13340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
207 De Benedetti F, Prencipe G, Bracaglia C, Marasco E, Grom AA. Targeting interferon-γ in hyperinflammation: opportunities and challenges. Nat Rev Rheumatol 2021;17:678-91. [PMID: 34611329 DOI: 10.1038/s41584-021-00694-z] [Reference Citation Analysis]
208 Braue JA, Al-Rohil RN. Yellow Periorbital Plaque and Retroperitoneal Fibrosis. JAMA Dermatol 2019;155:483-4. [PMID: 30785594 DOI: 10.1001/jamadermatol.2018.5233] [Reference Citation Analysis]
209 Cohen-Aubart F, Maksud P, Emile JF, Benameur N, Charlotte F, Cluzel P, Amoura Z, Haroche J. Efficacy of infliximab in the treatment of Erdheim-Chester disease. Ann Rheum Dis 2018;77:1387-90. [PMID: 29363511 DOI: 10.1136/annrheumdis-2017-212678] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
210 Chan WH, Shah A, Bae G, Hambro C, Martin BA, Brown R, Novoa R, Kwong BY. Disseminated non-Langerhans cell histiocytosis with an IRF2BP2-NTRK1 gene fusion identified by next-generation sequencing. JAAD Case Rep 2020;6:1156-8. [PMID: 33134460 DOI: 10.1016/j.jdcr.2020.05.032] [Reference Citation Analysis]
211 Liu J, Liang L, Cao X, Lu S. Indeterminate cell histiocytosis presenting as a single nodule on the scrotum of a child. Australas J Dermatol 2020;61:57-8. [PMID: 31155712 DOI: 10.1111/ajd.13089] [Reference Citation Analysis]
212 Ungari M, Ferrero G, Varotti E, Gusolfino MD, Manotti L, Tanzi G, Trombatore M, Bertoni R. Langerhans cell histiocytosis of an intra-mammary lymph node in an 18-year-old woman. Pathologica 2020;112:50-5. [PMID: 32202540 DOI: 10.32074/1591-951X-27-19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Gru AA, Dehner LP. Cutaneous Hematolymphoid and Histiocytic Proliferations in Children. Pediatr Dev Pathol 2018;21:208-51. [DOI: 10.1177/1093526617750947] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
214 Haroutunian SG, O'Brien KJ, Estrada-Veras JI, Yao J, Boyd LC, Mathur K, Gahl WA, Mirmomen SM, Malayeri AA, Kleiner DE, Jaffe ES, Gochuico BR. Clinical and Histopathologic Features of Interstitial Lung Disease in Erdheim⁻Chester Disease. J Clin Med 2018;7:E243. [PMID: 30154360 DOI: 10.3390/jcm7090243] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
215 Chugh A, Kaur A, Kumar Patnana A, Kumar P, Chugh VK. Unisystem Langerhans cell histiocytosis in maxillofacial region in pediatrics: comprehensive and systematic review. Oral Maxillofac Surg 2021. [PMID: 33591444 DOI: 10.1007/s10006-021-00949-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
216 Krooks J, Minkov M, Weatherall AG. Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis. J Am Acad Dermatol 2018;78:1035-44. [PMID: 29754885 DOI: 10.1016/j.jaad.2017.05.059] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 11.5] [Reference Citation Analysis]
217 Miao HL, Zhao AL, Duan MH, Zhou DB, Cao XX, Li J. Clinical presentation and prognostic analysis of adult patients with Langerhans cell histiocytosis with pulmonary involvement. BMC Cancer 2020;20:911. [PMID: 32967635 DOI: 10.1186/s12885-020-07421-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
218 Umakanth S, Lakshminarayana B, Kudva R. Concomitant malignancies in the neck: follicular dendritic cell sarcoma; a rare tumour presenting as a right-sided neck nodal mass and papillary carcinoma thyroid. BMJ Case Rep 2021;14:e244175. [PMID: 34789524 DOI: 10.1136/bcr-2021-244175] [Reference Citation Analysis]
219 Bruce-Brand C, Schneider JW, Schubert P. Rosai-Dorfman disease: an overview. J Clin Pathol. 2020;73:697-705. [PMID: 32591351 DOI: 10.1136/jclinpath-2020-206733] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
220 Cohen-Aubart F, Guerin M, Poupel L, Cluzel P, Saint-Charles F, Charlotte F, Arsafi Y, Emile JF, Frisdal E, Le Goff C, Donadieu J, Amoura Z, Lesnik P, Haroche J, Le Goff W. Hypoalphalipoproteinemia and BRAFV600E Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease. Arterioscler Thromb Vasc Biol 2018;38:1913-25. [PMID: 29930009 DOI: 10.1161/ATVBAHA.118.310803] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
221 Hao X, Feng R, Bi Y, Liu Y, Li C, Lu T, Tian Y. Dramatic efficacy of dabrafenib in Erdheim-Chester disease (ECD): a pediatric patient with multiple large intracranial ECD lesions hidden by refractory Langerhans cell histiocytosis. Journal of Neurosurgery: Pediatrics 2019;23:48-53. [DOI: 10.3171/2018.6.peds17728] [Cited by in Crossref: 8] [Article Influence: 2.7] [Reference Citation Analysis]
222 Alwani MM, Elghouche AN, Schueth EA, Campiti VJ, Matt BH, Yekinni AO. Manifestations of Pediatric Extranodal Rosai Dorfman Disease in the head and neck. Int J Pediatr Otorhinolaryngol 2020;131:109851. [PMID: 31901484 DOI: 10.1016/j.ijporl.2019.109851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
223 Ferrero E, Villa A, Stefanoni D, Nemkov T, D’alessandro A, Tengesdal I, Belloni D, Molteni R, Vergani B, De Luca G, Grassini G, Cangi MG, Dagna L, Doglioni C, Cavalli G, Ferrarini M. Immunometabolic activation of macrophages leads to cytokine production in the pathogenesis of KRAS -mutated histiocytosis. Rheumatology 2021. [DOI: 10.1093/rheumatology/keab869] [Reference Citation Analysis]
224 Minkov M. An update on the treatment of pediatric-onset Langerhans cell histiocytosis through pharmacotherapy. Expert Opinion on Pharmacotherapy 2018;19:233-42. [DOI: 10.1080/14656566.2018.1429405] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
225 Matter MS, Bihl M, Juskevicius D, Tzankov A. Is Rosai-Dorfman disease a reactve process? Detection of a MAP2K1 L115V mutation in a case of Rosai-Dorfman disease. Virchows Arch 2017;471:545-7. [PMID: 28597077 DOI: 10.1007/s00428-017-2173-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
226 Maietta A, Razmpoosh M. Erdheim-Chester Disease and Small Lymphocytic Lymphoma Collision Tumour Presenting as a Perirenal Mass. Case Rep Pathol 2020;2020:3081824. [PMID: 32351750 DOI: 10.1155/2020/3081824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
227 Lakatos K, Sterlich K, Pötschger U, Thiem E, Hutter C, Prosch H, Minkov M. Langerhans Cell Histiocytosis of the Orbit: Spectrum of Clinical and Imaging Findings. J Pediatr 2021;230:174-181.e1. [PMID: 33157073 DOI: 10.1016/j.jpeds.2020.10.056] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
228 Alruwaii ZI, Zhang Y, Larman T, Miller JA, Montgomery EA. Rosai-Dorfman Disease of the Digestive System—Beware Vasculopathy: A Clinicopathologic Analysis. American Journal of Surgical Pathology 2019;43:1644-52. [DOI: 10.1097/pas.0000000000001343] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
229 Haghighat Jahromi A, Goodman AM, Hoh CK. Rosai-Dorfman-Destombes (RDD) disease presenting as palindromic rheumatism. BMC Med Imaging 2021;21:72. [PMID: 33858362 DOI: 10.1186/s12880-021-00596-2] [Reference Citation Analysis]
230 Liang J, Alfano DN, Squires JE, Riley MM, Parks WT, Kofler J, El-Gharbawy A, Madan-Kheterpal S, Acquaro R, Picarsic J. Novel NLRC4 Mutation Causes a Syndrome of Perinatal Autoinflammation With Hemophagocytic Lymphohistiocytosis, Hepatosplenomegaly, Fetal Thrombotic Vasculopathy, and Congenital Anemia and Ascites. Pediatr Dev Pathol 2017;20:498-505. [PMID: 28403691 DOI: 10.1177/1093526616686890] [Cited by in Crossref: 35] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
231 Oneal PA, Kwitkowski V, Luo L, Shen YL, Subramaniam S, Shord S, Goldberg KB, McKee AE, Kaminskas E, Farrell A, Pazdur R. FDA Approval Summary: Vemurafenib for the Treatment of Patients with Erdheim-Chester Disease with the BRAFV600 Mutation. Oncologist 2018;23:1520-4. [PMID: 30120160 DOI: 10.1634/theoncologist.2018-0295] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
232 Carroll AS, Doherty CM, Blake J, Hunt SJ, Hoskote C, McNicholl F, Phadke R, Sheehy O, Bremner FD, D'Sa S, McNamara C, Reilly MM. Neurology and the histiocytoses: a case of Rosai-Dorfman-Destombes disease. Pract Neurol 2022:practneurol-2022-003398. [PMID: 35534197 DOI: 10.1136/practneurol-2022-003398] [Reference Citation Analysis]
233 Zhao CY, Kim J, Fernandez-Peñas P. Widespread nodules and papules in a patient with chronic myelomonocytic leukemia. Int J Dermatol 2020;59:1071-2. [PMID: 32358969 DOI: 10.1111/ijd.14899] [Reference Citation Analysis]
234 Buján Bonino C, Moreiras Arias N, Pérez Feal P, Pita da Veiga Seijo G, Suárez Peñaranda JM, Rosón López E. An unusual case of persistent congenital plaque-type indeterminate cell histiocytoma. Australas J Dermatol 2021;62:442-3. [PMID: 34042177 DOI: 10.1111/ajd.13635] [Reference Citation Analysis]
235 Zhou W, Rao J, Li C. Isolated Langerhans cell histiocytosis in the hypothalamic-pituitary region: a case report. BMC Endocr Disord 2019;19:143. [PMID: 31856773 DOI: 10.1186/s12902-019-0474-0] [Reference Citation Analysis]
236 Meazza Prina M, Martini F, Bracchi F, Di Mauro D, Fargnoli A, Motta M, Giussani C, Gobbin G, Taverna M, D'Alessio A. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report. BMC Infect Dis 2021;21:811. [PMID: 34388982 DOI: 10.1186/s12879-021-06532-7] [Reference Citation Analysis]
237 Ishikawa M, Endo Y, Uehara A, Suto M, Yasuda M, Motegi SI, Ishikawa O. Cutaneous adult xanthogranuloma with a small portion of BRAFV 600E mutated Langerhans cell histiocytosis populations: A case report and the review of published work. J Dermatol 2019;46:161-5. [PMID: 30536719 DOI: 10.1111/1346-8138.14725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
238 Wake L, Xi L, Raffeld M, Jaffe ES. Langerhans Cell Histiocytosis, Non-Langerhans histiocytosis and concurrent Papillary Thyroid Carcinoma with BRAF V600E mutations: A case report and literature review. Hum Pathol (N Y) 2019;17:200302. [PMID: 31592429 DOI: 10.1016/j.hpcr.2019.200302] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
239 Goyal G, Young JR, Koster MJ, Tobin WO, Vassallo R, Ryu JH, Davidge-Pitts CJ, Hurtado MD, Ravindran A, Sartori Valinotti JC, Bennani NN, Shah MV, Rech KL, Go RS; Mayo Clinic Histiocytosis Working Group. The Mayo Clinic Histiocytosis Working Group Consensus Statement for the Diagnosis and Evaluation of Adult Patients With Histiocytic Neoplasms: Erdheim-Chester Disease, Langerhans Cell Histiocytosis, and Rosai-Dorfman Disease. Mayo Clin Proc 2019;94:2054-71. [PMID: 31472931 DOI: 10.1016/j.mayocp.2019.02.023] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 10.7] [Reference Citation Analysis]
240 Xu J, Ma L. Dermoscopic Patterns in Juvenile Xanthogranuloma Based on the Histological Classification. Front Med (Lausanne) 2020;7:618946. [PMID: 33521026 DOI: 10.3389/fmed.2020.618946] [Reference Citation Analysis]
241 Hountondji L, Debourdeau A, Meunier L. Acute liver failure secondary to langerhans cell histiocytosis. Clin Res Hepatol Gastroenterol 2021;:101744. [PMID: 34146728 DOI: 10.1016/j.clinre.2021.101744] [Reference Citation Analysis]
242 Abid MB, Wadera K, Bird JM, Pawade J, Marks DI. Alemtuzumab-based therapy for Secondary Malignant Histiocytosis arising from Pre-B-ALL. Leuk Res Rep 2018;9:5-8. [PMID: 29264111 DOI: 10.1016/j.lrr.2017.11.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
243 Esmaeili M, Fischer AS, Khurana M, Gru AA, Yan AC, Rubin AI. Shapiro xanthogranuloma: An essential diagnosis for dermatologists and dermatopathologists to recognize to avoid misdiagnosis of a hematopoietic malignancy in infants and neonates. J Cutan Pathol 2021;48:558-62. [PMID: 32713034 DOI: 10.1111/cup.13823] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
244 Vassallo R, Harari S, Tazi A. Current understanding and management of pulmonary Langerhans cell histiocytosis. Thorax. 2017;72:937-945. [PMID: 28689173 DOI: 10.1136/thoraxjnl-2017-210125] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 10.0] [Reference Citation Analysis]
245 Fayne R, Rengifo SS, Gonzalez I, Solorzano JL, Gonzalez D, Vega F, Cho-Vega JH. Primary cutaneous Rosai-Dorfman disease; a case-based review of a diagnostically and therapeutically challenging rare variant. Ann Diagn Pathol 2020;45:151446. [PMID: 31978810 DOI: 10.1016/j.anndiagpath.2019.151446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
246 Aróstegui Aguilar J, Diago A, Carrillo Gijón R, Fernández Figueras M, Fraga J, García Herrera A, Garrido M, Idoate Gastearena MÁ, Christian Laga Á, Llamas-Velasco M, Martínez Campayo N, Monteagudo C, Onrubia J, Pérez Muñoz N, Ríos-Martín JJ, Ríos-Viñuela E, Rodríguez Peralto JL, Rozas Muñoz E, Sanmartín O, Santonja C, Santos-Briz Á, Saus C, Suárez Peñaranda JM, Velasco Benito V, Beato Merino MJ, Fernandez-Flores A. Granulomas in Dermatopathology: Principal Diagnoses - Part 1. Actas Dermosifiliogr 2021:S0001-7310(21)00139-3. [PMID: 33887235 DOI: 10.1016/j.ad.2021.04.002] [Reference Citation Analysis]
247 Ang WW, Bundele MM, Shelat VG. Follicular dendritic cell sarcoma: Rare presentation of incidental large hepatic mass. Ann Hepatobiliary Pancreat Surg. 2019;23:74-76. [PMID: 30863812 DOI: 10.14701/ahbps.2019.23.1.74] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
248 Yuan S, Wang Y, Luo H, Jiang Z, Qiao B, Jiang Y, Hu Y, Cheng Y, Chen X, Gong W, Huang Y, Zhao W, Luo D, Liu B, Su H, Zhou J, Song S. Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis. Br J Haematol 2020;189:72-83. [PMID: 31960419 DOI: 10.1111/bjh.16299] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
249 Schulert GS. The Storm Beneath the Storm: MAS-HLH in Inflammatory Myopathies. J Rheumatol 2020;47:1461-3. [PMID: 33004480 DOI: 10.3899/jrheum.191274] [Reference Citation Analysis]
250 Gaspar BL, Vasishta RK, Das R, Bhalla A. Erdheim-Chester disease with unusual clinicopathological features complicated by DRESS syndrome, disseminated Cytomegalovirus infection and hemophagocytic lymphohistiocytosis. APMIS 2017;125:669-76. [PMID: 28418177 DOI: 10.1111/apm.12694] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
251 Raciborska A, Bilska K, Węcławek-Tompol J, Gryniewicz-Kwiatkowska O, Hnatko-Kołacz M, Stefanowicz J, Pieczonka A, Jankowska K, Pierelejewski F, Ociepa T, Sobol-Milejska G, Muszyńska-Rosłan K, Michoń O, Badowska W, Radwańska M, Drabko K. Clinical characteristics and outcome of pediatric patients diagnosed with Langerhans cell histiocytosis in pediatric hematology and oncology centers in Poland. BMC Cancer 2020;20:874. [PMID: 32917181 DOI: 10.1186/s12885-020-07366-3] [Reference Citation Analysis]
252 Numbere N, Pukhalskaya T, Bowman B, Campbell K, Smoller B. Progressive Nodular Histiocytosis: Report of a Case and Review of the Literature. Case Rep Pathol 2021;2021:5531820. [PMID: 34567817 DOI: 10.1155/2021/5531820] [Reference Citation Analysis]
253 Lai CY, Pettit T. Immune Thrombocytopenia in a Child With Refractory Langerhans Cell Histiocytosis Following Cladribine Containing Therapy. J Pediatr Hematol Oncol 2019;41:620-3. [PMID: 29889804 DOI: 10.1097/MPH.0000000000001243] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
254 Kenee P, Peters BR. Atypical Extranodal Skull Base Rosai-Dorfman Disease in a Pediatric Patient. OTO Open 2021;5:2473974X211054440. [PMID: 34723052 DOI: 10.1177/2473974X211054440] [Reference Citation Analysis]
255 Patti G, Ibba A, Morana G, Napoli F, Fava D, di Iorgi N, Maghnie M. Central diabetes insipidus in children: Diagnosis and management. Best Pract Res Clin Endocrinol Metab 2020;34:101440. [PMID: 32646670 DOI: 10.1016/j.beem.2020.101440] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
256 Chen C, Gu G, Zhou T, Huang M, Xia Q. Combination of Neoadjuvant Therapy and Liver Transplantation in Pediatric Multisystem Langerhans Cell Histiocytosis With Liver Involvement. Front Oncol 2020;10:566987. [PMID: 33117696 DOI: 10.3389/fonc.2020.566987] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
257 Kiyohara T, Nakamaru S, Miyamoto M, Shijimaya T, Nagano N, Makimura K, Takama H, Akiyama M, Tanimura H. Indeterminate dendritic cell neoplasm accompanied by eosinophilic pneumonia successfully treated by systemic steroid therapy: Report of the first case with muscular and parotid involvement and review of published work. J Dermatol 2018;45:1444-7. [PMID: 30320463 DOI: 10.1111/1346-8138.14673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
258 Vojvodić AR, Mijušković Ž, Kandolf Sekulović L. Indeterminate Cell Histiocytosis – Case Report and Review of Literature. Serbian Journal of Dermatology and Venereology 2018;10:18-24. [DOI: 10.2478/sjdv-2018-0004] [Reference Citation Analysis]
259 Jain P, Surrey LF, Straka J, Russo P, Womer R, Li MM, Storm PB, Waanders AJ, Hogarty MD, Resnick AC, Picarsic J. BRAF fusions in pediatric histiocytic neoplasms define distinct therapeutic responsiveness to RAF paradox breakers. Pediatr Blood Cancer 2021;68:e28933. [PMID: 33565241 DOI: 10.1002/pbc.28933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Héritier S, Hélias-Rodzewicz Z, Chakraborty R, Sengal AG, Bellanné-Chantelot C, Thomas C, Moreau A, Fraitag S, Allen CE, Donadieu J, Emile JF. New somatic BRAF splicing mutation in Langerhans cell histiocytosis. Mol Cancer 2017;16:115. [PMID: 28679432 DOI: 10.1186/s12943-017-0690-z] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
261 Shen W, Chang Liao N, Lin T, Wu P. Co-existence of Langerhans cell histiocytosis and reticulohistiocytosis with initial presentation of skull lesions: A case report. J Cutan Pathol 2019;46:62-6. [DOI: 10.1111/cup.13362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
262 Farris M, Hughes RT, Lamar Z, Soike MH, Menke JR, Ohgami RS, Winkfield K. Histiocytic Sarcoma Associated With Follicular Lymphoma: Evidence for Dramatic Response With Rituximab and Bendamustine Alone and a Review of the Literature. Clinical Lymphoma Myeloma and Leukemia 2019;19:e1-8. [DOI: 10.1016/j.clml.2018.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
263 Hughes NM, Jacene HA. PET Imaging for Hematologic Malignancies. Radiol Clin North Am 2021;59:705-23. [PMID: 34392914 DOI: 10.1016/j.rcl.2021.05.003] [Reference Citation Analysis]
264 Rezuș E, Burlui MA, Cardoneanu A, Haba D, Danciu M, Cozma RS, Rezuș C. Multicentric Reticulohistiocytosis Exhibiting Positive HLA-B*07 and HLA-B*08: A Case Report. Medicina (Kaunas) 2020;56:E456. [PMID: 32911791 DOI: 10.3390/medicina56090456] [Reference Citation Analysis]
265 Lee MJ, Park BS, Yoo YM, Jung HJ, Park JE. A Study of Central Diabetes Insipidus in Head and Neck Langerhans Cell Histiocytosis: A Single Center Experience. Clin Pediatr Hematol Oncol 2018;25:136-41. [DOI: 10.15264/cpho.2018.25.2.136] [Reference Citation Analysis]
266 Myrdal CN, Stratton DB, Davis TL, Curiel-Lewandrowski C. Generalised eruptive histiocytosis preceded by systemic symptoms. BMJ Case Rep 2021;14:e243411. [PMID: 34162620 DOI: 10.1136/bcr-2021-243411] [Reference Citation Analysis]
267 Gao J, Pasion J, Sanchez-Petitto G, Law J. Influenza virus B-associated hemophagocytic lymphohistiocytosis. Hematol Rep 2019;11:8268. [PMID: 31579142 DOI: 10.4081/hr.2019.8268] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
268 Chazal T, Costopoulos M, Maillart E, Fleury C, Psimaras D, Legendre P, Pineton de Chambrun M, Haroche J, Lubetzki C, Amoura Z, Legarff-Tavernier M, Cohen Aubart F. The cerebrospinal fluid CD4/CD8 ratio and interleukin-6 and -10 levels in neurosarcoidosis: a multicenter, pragmatic, comparative study. Eur J Neurol 2019;26:1274-80. [PMID: 31021023 DOI: 10.1111/ene.13975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
269 Costin A, Cerejeira D, Alves J. Generalised eruptive histiocytosis: Case report. Australas J Dermatol 2019;60:e314-6. [PMID: 31012082 DOI: 10.1111/ajd.13062] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
270 Fernández-Aceñero MJ, Pérez Alonso P, Díaz Del Arco C. Histiocytic sarcoma with bladder involvement: Case report and literature review. Rev Esp Patol 2018;51:23-6. [PMID: 29290317 DOI: 10.1016/j.patol.2017.01.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
271 Papo M, Diamond EL, Cohen-Aubart F, Emile JF, Roos-Weil D, Gupta N, Durham BH, Ozkaya N, Dogan A, Ulaner GA, Rampal R, Kahn JE, Sené T, Charlotte F, Hervier B, Besnard C, Bernard OA, Settegrana C, Droin N, Hélias-Rodzewicz Z, Amoura Z, Abdel-Wahab O, Haroche J. High prevalence of myeloid neoplasms in adults with non-Langerhans cell histiocytosis. Blood 2017;130:1007-13. [PMID: 28679734 DOI: 10.1182/blood-2017-01-761718] [Cited by in Crossref: 54] [Cited by in F6Publishing: 51] [Article Influence: 10.8] [Reference Citation Analysis]
272 Donadieu J, Larabi IA, Tardieu M, Visser J, Hutter C, Sieni E, Kabbara N, Barkaoui M, Miron J, Chalard F, Milne P, Haroche J, Cohen F, Hélias-Rodzewicz Z, Simon N, Jehanne M, Kolenova A, Pagnier A, Aladjidi N, Schneider P, Plat G, Lutun A, Sonntagbauer A, Lehrnbecher T, Ferster A, Efremova V, Ahlmann M, Blanc L, Nicholson J, Lambilliote A, Boudiaf H, Lissat A, Svojgr K, Bernard F, Elitzur S, Golan M, Evseev D, Maschan M, Idbaih A, Slater O, Minkov M, Taly V, Collin M, Alvarez JC, Emile JF, Héritier S. Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study. J Clin Oncol 2019;37:2857-65. [PMID: 31513482 DOI: 10.1200/JCO.19.00456] [Cited by in Crossref: 47] [Cited by in F6Publishing: 14] [Article Influence: 15.7] [Reference Citation Analysis]
273 Syrykh C, Ysebaert L, Péricart S, Evrard SM, Meggetto F, Kanoun S, Brousset P, Laurent C. ALK-positive histiocytosis associated with chronic lymphocytic leukaemia/small lymphocytic lymphoma: a multitarget response under ibrutinib. Virchows Arch 2021;478:779-83. [PMID: 33011863 DOI: 10.1007/s00428-020-02937-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
274 Riller Q, Rieux-Laucat F. RASopathies: from germline mutations to somatic and multigenic diseases. Biomed J 2021:S2319-4170(21)00070-6. [PMID: 34175492 DOI: 10.1016/j.bj.2021.06.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
275 Pierry C, Caumont C, Blanchard E, Brochet C, Dournes G, Gros A, Bandres T, Verdon S, Marty M, Bégueret H, Merlio J. Assessment of BRAFV600E mutation in pulmonary Langerhans cell histiocytosis in tissue biopsies and bronchoalveolar lavages by droplet digital polymerase chain reaction. Virchows Arch 2018;472:247-58. [DOI: 10.1007/s00428-017-2185-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
276 Phan DAT, Phung GB, Duong TT, Hoang AV, Ngo QD, Trinh DTN, Tran TT. The Value of BRAF VE1 Immunoexpression in Pediatric Langerhans Cell Histiocytosis. Fetal Pediatr Pathol 2020;:1-11. [PMID: 33295826 DOI: 10.1080/15513815.2020.1857483] [Reference Citation Analysis]
277 Piris MA, Aguirregoicoa E, Montes-moreno S, Celeiro-muñoz C. Castleman Disease and Rosai-Dorfman Disease. Seminars in Diagnostic Pathology 2018;35:44-53. [DOI: 10.1053/j.semdp.2017.11.014] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
278 Ruby KN, Deng AC, Zhang J, Leblanc RE, Linos KD, Yan S. Emperipolesis and S100 expression may be seen in cutaneous xanthogranulomas: A multi-institutional observation. J Cutan Pathol 2018;45:667-73. [DOI: 10.1111/cup.13285] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
279 Vaquier L, Abitbol C, Emile J, Dossier A, Guyard A, Hourseau M. Histiocytose de Rosai-Dorfman-Destombes extra-ganglionnaire du maxillaire : à propos d’un cas et revue de la littérature. Annales de Pathologie 2022. [DOI: 10.1016/j.annpat.2021.12.006] [Reference Citation Analysis]
280 Lian H, Cui L, Yang Y, Wei A, Cheng H, Li N, Zhang L, Ma H, Zhao X, Wang T, Li Z, Zhang R. Second-line regimen for CNS-involved pediatric Langerhans cell histiocytosis. Pituitary 2021. [PMID: 34302575 DOI: 10.1007/s11102-021-01176-x] [Reference Citation Analysis]
281 Picarsic J, Pysher T, Zhou H, Fluchel M, Pettit T, Whitehead M, Surrey LF, Harding B, Goldstein G, Fellig Y, Weintraub M, Mobley BC, Sharples PM, Sulis ML, Diamond EL, Jaffe R, Shekdar K, Santi M. BRAF V600E mutation in Juvenile Xanthogranuloma family neoplasms of the central nervous system (CNS-JXG): a revised diagnostic algorithm to include pediatric Erdheim-Chester disease. Acta Neuropathol Commun 2019;7:168. [PMID: 31685033 DOI: 10.1186/s40478-019-0811-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
282 Sathyanarayanan V, Issa A, Pinto R, Fayad LE, Loghavi S, Hagemeister F, Westin JR. Rosai-Dorfman Disease: The MD Anderson Cancer Center Experience. Clin Lymphoma Myeloma Leuk 2019;19:709-14. [PMID: 31446000 DOI: 10.1016/j.clml.2019.06.013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
283 Ballester LY, Cantu MD, Lim KPH, Sarabia SF, Ferguson LS, Renee Webb C, Allen CE, McClain KL, Mohila CA, Punia JN, Roy A, López-Terrada DH, John Hicks M, Fisher KE. The use of BRAF V600E mutation-specific immunohistochemistry in pediatric Langerhans cell histiocytosis. Hematol Oncol 2018;36:307-15. [PMID: 28219109 DOI: 10.1002/hon.2388] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
284 Phulware RH, Guleria P, Iyer VK, Bakhshi S, Seth R, Mridha AR, Jain D, Mallick S, Arava SK, Agarwal S, Kaushal S, Yadav R, Mathur SR. Cytological diagnosis of Langerhans cell histiocytosis: A series of 47 cases. Cytopathology 2019;30:413-8. [DOI: 10.1111/cyt.12709] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
285 Pegoraro F, Brambilla A, Coniglio ML, Caputo R, Perrone A, Buccoliero AM, Favre C, Sieni E. Severe ocular involvement in a newborn with Langerhans Cell Histiocytosis. Pediatric Hematology Oncology Journal 2021;6:55-6. [DOI: 10.1016/j.phoj.2020.10.006] [Reference Citation Analysis]
286 Su H, Wu W, Guo Y, Chen H, Shan S. Paediatric Erdheim–Chester disease with aggressive skin manifestations. Br J Dermatol 2018;178:261-4. [DOI: 10.1111/bjd.15306] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
287 Lin M, Park S, Hayden A, Giustini D, Trinkaus M, Pudek M, Mattman A, Schneider M, Chen LYC. Clinical utility of soluble interleukin-2 receptor in hemophagocytic syndromes: a systematic scoping review. Ann Hematol. 2017;96:1241-1251. [PMID: 28497365 DOI: 10.1007/s00277-017-2993-y] [Cited by in Crossref: 52] [Cited by in F6Publishing: 48] [Article Influence: 10.4] [Reference Citation Analysis]
288 Miron G, Karni A, Faust-Soher A, Giladi N, Alroy H, Gadoth A. Erdheim-Chester disease presenting with chorea and mimicking IgG4-related disorder. Neurol Clin Pract 2019;9:524-6. [PMID: 32042499 DOI: 10.1212/CPJ.0000000000000617] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
289 Cho MH, Jung HJ, Han JH, Park JE. A Case of Recurrent Rosai-Dorfman Disease Successfully Treated with 2-Chlorodeoxyadenosine (Cladribine). Clin Pediatr Hematol Oncol 2019;26:99-104. [DOI: 10.15264/cpho.2019.26.2.99] [Reference Citation Analysis]
290 Park H, Nishino M, Hornick JL, Jacobsen ED. Imaging of Histiocytosis in the Era of Genomic Medicine. Radiographics 2019;39:95-114. [PMID: 30500304 DOI: 10.1148/rg.2019180054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
291 Haroche J, Cohen-Aubart F, Amoura Z. Erdheim-Chester disease. Blood 2020;135:1311-8. [PMID: 32107533 DOI: 10.1182/blood.2019002766] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
292 Chen Q, Lee JS, Liang MW, Chan MMF, Pujol RM, Requena L, Tan SH. Indeterminate cell histiocytosis in a Chinese patient with progressive and extensive nodular lesions and mixed indeterminate cell and macrophage-monocyte lineage. J Cutan Pathol 2018;45:428-33. [PMID: 29469188 DOI: 10.1111/cup.13132] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
293 Luo L, Li YX. Pulmonary Langerhans cell histiocytosis and multiple system involvement: A case report. World J Clin Cases 2021; 9(35): 11029-11035 [DOI: 10.12998/wjcc.v9.i35.11029] [Reference Citation Analysis]
294 Ocak S, Bayramoglu Z, Tugcu D, Karaman S, Unuvar A, Karakas Z. Mixed Langerhans Cell Histiocytosis and Erdheim-Chester Disease in a Girl: A Rare and Puzzling Diagnosis. J Pediatr Hematol Oncol 2021;43:e375-9. [PMID: 32097280 DOI: 10.1097/MPH.0000000000001770] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Zhu P, Li N, Yu L, Miranda MN, Wang G, Duan Y. Erdheim-Chester Disease with Emperipolesis: A Unique Case Involving the Heart. Cancer Res Treat 2017;49:553-8. [PMID: 27488869 DOI: 10.4143/crt.2016.078] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
296 Boyuk E, Bulur I, Canaz F, Cilingir O. Adult Onset Langerhans Cell Histiocytosis Diagnosed With Xanthomalike Plaque. Actas Dermosifiliogr (Engl Ed) 2020;111:71-3. [PMID: 31530379 DOI: 10.1016/j.ad.2018.06.028] [Reference Citation Analysis]
297 Morice A, Fraitag S, Miquel C, Rose CS, Puget S. Systemic juvenile xanthogranuloma: a case of spontaneous regression of intramedullary spinal cord, cerebral, and cutaneous lesions. Journal of Neurosurgery: Pediatrics 2017;20:556-60. [DOI: 10.3171/2017.6.peds17113] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
298 Facchetti F, Pileri SA, Lorenzi L, Tabanelli V, Rimsza L, Pittaluga S, Dirnhofer S, Copie-Bergman C, de Leval L, Rosenwald A, Wotherspoon A, Fend F. Histiocytic and dendritic cell neoplasms: what have we learnt by studying 67 cases. Virchows Arch 2017;471:467-89. [PMID: 28695297 DOI: 10.1007/s00428-017-2176-1] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 6.6] [Reference Citation Analysis]
299 Cohen-Aubart F, Ungureanu I, Razanamahery J, Charlotte F, Valmary-Degano S, Hélias-Rodzewicz Z, Cazals-Hatem D, Dartigues P, Delage-Corre M, Selves J, Tas P, Humbert S, Malakhia A, Kunnamo M, Veresezan L, Prokopiou C, Seeber A, Tazi A, Donadieu J, Lucidarme O, Haroche J, Emile JF. Peritoneal or mesenteric tumours revealing histiocytosis. BMJ Open Gastroenterol 2021;8:e000622. [PMID: 34020934 DOI: 10.1136/bmjgast-2021-000622] [Reference Citation Analysis]
300 Moyon Q, Boussouar S, Maksud P, Emile JF, Charlotte F, Aladjidi N, Prévot G, Donadieu J, Amoura Z, Grenier P, Haroche J, Cohen Aubart F. Lung Involvement in Destombes-Rosai-Dorfman Disease: Clinical and Radiological Features and Response to the MEK Inhibitor Cobimetinib. Chest 2020;157:323-33. [PMID: 31669429 DOI: 10.1016/j.chest.2019.09.036] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
301 Razanamahery J, Dresco F, Emile JF, Verhoeven F, Algros MP, Lodovichetti J, Humbert S, Bouiller K, Magy-Bertrand N. Sacroiliitis in a patient with Rosai-Dorfman disease: new bone location or overlap with axial spondylarthritis? Rheumatology (Oxford) 2020;59:2168-70. [PMID: 31943104 DOI: 10.1093/rheumatology/kez675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Schenk T, Birndt S, Rosée PL. Hämophagozytische Syndrome beim Erwachsenen. Aktuelle Rheumatologie 2020;45:550-8. [DOI: 10.1055/a-1252-2287] [Reference Citation Analysis]
303 Zhao AL, Cai H, Chen J, Duan MH, Zhou DB, Li J, Cao XX. The potential of cell-free DNA to reveal the molecular profiles of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Leukemia 2022. [PMID: 35173275 DOI: 10.1038/s41375-022-01523-2] [Reference Citation Analysis]
304 Jimbo H, Fujiwara S, Nagai H, Nishigori C. Case of histiocytosis with bone involvement of fingers successfully treated with peginterferon-α. J Dermatol 2019;46:e94-5. [PMID: 30151837 DOI: 10.1111/1346-8138.14609] [Reference Citation Analysis]
305 Roeser A, Cohen-Aubart F, Breillat P, Miyara M, Emile JF, Charlotte F, Donadieu J, Amoura Z, Haroche J. Autoimmunity associated with Erdheim-Chester disease improves with BRAF/MEK inhibitors. Haematologica 2019;104:e502-5. [PMID: 30923093 DOI: 10.3324/haematol.2018.214007] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
306 Sher AC, Orth R, Mcclain K, Allen C, Hayatghaibi S, Seghers V. PET/MR in the Assessment of Pediatric Histiocytoses: A Comparison to PET/CT. Clinical Nuclear Medicine 2017;42:582-8. [DOI: 10.1097/rlu.0000000000001717] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
307 Xerri L, Adélaïde J, Popovici C, Garnier S, Guille A, Mescam-mancini L, Laurent C, Brousset P, Coze C, Michel G, Chaffanet M, Bouabdallah R, Coso D, Bertucci F, Birnbaum D. CDKN2A/B Deletion and Double-hit Mutations of the MAPK Pathway Underlie the Aggressive Behavior of Langerhans Cell Tumors. American Journal of Surgical Pathology 2018;42:150-9. [DOI: 10.1097/pas.0000000000000989] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
308 Garg D, Pedapati R, Nakra T, Singh RK, Prabhakar A, Dash D, Bhatia R, Tripathi M. Langerhans cell histiocytosis presenting as a rapidly evolving frontotemporal syndrome. Neurol Sci 2019;40:1055-8. [DOI: 10.1007/s10072-019-3709-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
309 Wei L, Yang L, Cong J, Ye J, Li X, Yao N, Yang J, Ding J, Wang J. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis. J Cancer Res Clin Oncol 2021;147:863-9. [PMID: 33025280 DOI: 10.1007/s00432-020-03376-7] [Reference Citation Analysis]
310 Ravindran A, Goyal G, Go RS, Rech KL; Mayo Clinic Histiocytosis Working Group. Rosai-Dorfman Disease Displays a Unique Monocyte-Macrophage Phenotype Characterized by Expression of OCT2. Am J Surg Pathol 2021;45:35-44. [PMID: 33177341 DOI: 10.1097/PAS.0000000000001617] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
311 Bendari M, Chamizakhraji I, Elamari S, Oqbani K, Ahnach M. Unusual Cutaneous Location of Langheransian Histiocytosis: A Case Report. Cureus. [DOI: 10.7759/cureus.19617] [Reference Citation Analysis]
312 Cohen Aubart F, Idbaih A, Emile JF, Amoura Z, Abdel-Wahab O, Durham BH, Haroche J, Diamond EL. Histiocytosis and the nervous system: from diagnosis to targeted therapies. Neuro Oncol 2021:noab107. [PMID: 33993305 DOI: 10.1093/neuonc/noab107] [Reference Citation Analysis]
313 Luo S, Guo Z, Zhou Y, Zhang G. Generalized Eruptive Histiocytoma With S100 Protein-Positive Histiocytes and Prominent Eosinophilic Infiltration: A Rare Case Report. Am J Dermatopathol 2022. [PMID: 35316823 DOI: 10.1097/DAD.0000000000002182] [Reference Citation Analysis]
314 Jouenne F, Benattia A, Tazi A. Mitogen-activating protein kinase pathway alterations in Langerhans cell histiocytosis. Curr Opin Oncol 2021;33:101-9. [PMID: 33315630 DOI: 10.1097/CCO.0000000000000707] [Reference Citation Analysis]
315 Huri G, Çetik RM, Gedikoğlu G, Garbis N. Synovial Non-langerhans Cell Histiocytosis of the Shoulder: A Case Report and Review of the Literature. J Orthop Case Rep 2020;10:6-10. [PMID: 33708700 DOI: 10.13107/jocr.2020.v10.i08.1834] [Reference Citation Analysis]
316 Mosheimer BA, Oppl B, Zandieh S, Fillitz M, Keil F, Klaushofer K, Weiss G, Zwerina J. Bone Involvement in Rosai-Dorfman Disease (RDD): a Case Report and Systematic Literature Review. Curr Rheumatol Rep. 2017;19:29. [PMID: 28401384 DOI: 10.1007/s11926-017-0656-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
317 Cohen-Aubart F, Emile JF, Carrat F, Helias-Rodzewicz Z, Taly V, Charlotte F, Cluzel P, Donadieu J, Idbaih A, Barete S, Amoura Z, Haroche J. Phenotypes and survival in Erdheim-Chester disease: Results from a 165-patient cohort. Am J Hematol. 2018;93:E114-E117. [PMID: 29396850 DOI: 10.1002/ajh.25055] [Cited by in Crossref: 40] [Cited by in F6Publishing: 36] [Article Influence: 10.0] [Reference Citation Analysis]
318 Tzankov A, Kremer M, Leguit R, Orazi A, van der Walt J, Gianelli U, Hebeda KM. Histiocytic cell neoplasms involving the bone marrow: summary of the workshop cases submitted to the 18th Meeting of the European Association for Haematopathology (EAHP) organized by the European Bone Marrow Working Group, Basel 2016. Ann Hematol 2018;97:2117-28. [PMID: 30084011 DOI: 10.1007/s00277-018-3436-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
319 McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, Picarsic J, Ribeiro KB, Allen CE. Histiocytic disorders. Nat Rev Dis Primers 2021;7:73. [PMID: 34620874 DOI: 10.1038/s41572-021-00307-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
320 Kobayashi M, Tojo A. Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment. Cancer Sci. 2018;109:3707-3713. [PMID: 30281871 DOI: 10.1111/cas.13817] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
321 Wang FF, Liu YS, Zhu WB, Liu YD, Chen Y. Pulmonary Langerhans cell histiocytosis in adults: A case report. World J Clin Cases 2019; 7(14): 1892-1898 [PMID: 31417936 DOI: 10.12998/wjcc.v7.i14.1892] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
322 Kuzyk A, Silver S, Wallace S, Hamza S, Toole J. A Case Indistinguishable Between Indeterminate Cell Histiocytosis and Cutaneous Rosai-Dorfman Disease. J Cutan Med Surg 2017;21:68-71. [PMID: 27507795 DOI: 10.1177/1203475416664038] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
323 Oliveira TE, Tarlé RG, Mesquita LAF. Dermoscopy in the diagnosis of juvenile xanthogranuloma. An Bras Dermatol 2018;93:138-40. [PMID: 29641718 DOI: 10.1590/abd1806-4841.20186849] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
324 Fernandes AM, Narayanaswamy S, Pai SA. Serendipitous discovery in a fistula-in-ano. J Clin Pathol 2021;74:e4. [PMID: 32796049 DOI: 10.1136/jclinpath-2020-206690] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
325 Bergsten E, Horne A, Aricó M, Astigarraga I, Egeler RM, Filipovich AH, Ishii E, Janka G, Ladisch S, Lehmberg K, McClain KL, Minkov M, Montgomery S, Nanduri V, Rosso D, Henter JI. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood 2017;130:2728-38. [PMID: 28935695 DOI: 10.1182/blood-2017-06-788349] [Cited by in Crossref: 218] [Cited by in F6Publishing: 184] [Article Influence: 43.6] [Reference Citation Analysis]
326 Néel A, Artifoni M, Fontenoy AM, Tessoulin B, Lorillon G, Cohen-Aubart F, Haroche J, Genereau T, de Menthon M, Guillevin L, Maillard H, Kahn JE, Hermine O, Araujo C, Dromer C, Jullien D, Hamidou M, Donadieu J, Tazi A. Long-term efficacy and safety of 2CdA (cladribine) in extra-pulmonary adult-onset Langerhans cell histiocytosis: analysis of 23 cases from the French Histiocytosis Group and systematic literature review. Br J Haematol 2020;189:869-78. [PMID: 32191819 DOI: 10.1111/bjh.16449] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
327 Takahashi S, Muto J, Takama H, Yanagishita T, Takeo T, Ohshima Y, Watanabe D. Generalized eruptive histiocytoma: Pediatric case report and review of the published work. J Dermatol 2019;46:e407-8. [PMID: 31254297 DOI: 10.1111/1346-8138.15005] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
328 Kalmuk J, Matar S, Feng G, Kilb E, Lim MY. Parvovirus B19-induced hemophagocytic lymphohistiocytosis: Case report and review of the literature. Clin Case Rep 2019;7:2076-81. [PMID: 31788255 DOI: 10.1002/ccr3.2401] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
329 Hilal T, Dicaudo DJ, Connolly SM, Reeder CB. Necrobiotic xanthogranuloma: a 30-year single-center experience. Ann Hematol 2018;97:1471-9. [DOI: 10.1007/s00277-018-3301-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
330 Thomas KD, Delahoussaye P, Schwartz MR, Ayala AG, Ro JY. Extranodal Rosai-Dorfman disease involving soft tissue associated with increased IgG4 plasma cells. Human Pathology: Case Reports 2021;24:200488. [DOI: 10.1016/j.ehpc.2021.200488] [Reference Citation Analysis]
331 Mastropolo R, Close A, Allen SW, McClain KL, Maurer S, Picarsic J. BRAF-V600E-mutated Rosai-Dorfman-Destombes disease and Langerhans cell histiocytosis with response to BRAF inhibitor. Blood Adv 2019;3:1848-53. [PMID: 31213430 DOI: 10.1182/bloodadvances.2019000093] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
332 Holloman A, Panchal S, Mistry E, Monroig-Bosque P, Christensen P, Lai E, Cykowski M. A 57-year-old woman with falls, slurred speech, and abnormal MRI signal in the pons, middle cerebellar peduncles, and cerebellum. Brain Pathol 2022;:e13072. [PMID: 35486393 DOI: 10.1111/bpa.13072] [Reference Citation Analysis]
333 Facchetti F, Lonardi S, Vermi W, Lorenzi L. Updates in histiocytic and dendritic cell proliferations and neoplasms. Diagnostic Histopathology 2019;25:217-28. [DOI: 10.1016/j.mpdhp.2019.04.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
334 Hamza S, Kuzyk A, Silver S, Wallace S, Toole J. It May Look Similar to a Xanthogranuloma Under the Microscope but It Does Not Really Walk Like One Clinically . . . J Cutan Med Surg 2017;21:473-4. [PMID: 28920472 DOI: 10.1177/1203475417716332] [Reference Citation Analysis]
335 Cleven AHG, Hogendoorn PCW. Hematopoietic Tumors Primarily Presenting in Bone. Surg Pathol Clin 2017;10:675-91. [PMID: 28797508 DOI: 10.1016/j.path.2017.04.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
336 Fraitag S, Emile J. Cutaneous histiocytoses in children. Histopathology 2022;80:196-215. [DOI: 10.1111/his.14569] [Reference Citation Analysis]
337 Zhang Q, Shibani A, Sadikovic B, Howlett CJ, Ang L. An aggressive multifocal primary CNS histiocytosis with PTPN11 (Shp2) mutation. Neuropathol Appl Neurobiol 2018;44:240-3. [DOI: 10.1111/nan.12404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
338 Sunnapwar A, Menias CO, Ojili V, Policarpio Nicolas M, Katre R, Gangadhar K, Nagar A. Abdominal manifestations of histiocytic disorders in adults: imaging perspective. Br J Radiol 2016;89:20160221. [PMID: 27332519 DOI: 10.1259/bjr.20160221] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
339 Emile JF, Cohen-Aubart F, Collin M, Fraitag S, Idbaih A, Abdel-Wahab O, Rollins BJ, Donadieu J, Haroche J. Histiocytosis. Lancet 2021;398:157-70. [PMID: 33901419 DOI: 10.1016/S0140-6736(21)00311-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
340 Barclay M, Devaney R, Bhatt JM. Paediatric pulmonary Langerhans cell histiocytosis. Breathe (Sheff) 2020;16:200003. [PMID: 32684994 DOI: 10.1183/20734735.0003-2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Hutter C, Minkov M. Insights into the pathogenesis of Langerhans cell histiocytosis: the development of targeted therapies. Immunotargets Ther 2016;5:81-91. [PMID: 27785447 DOI: 10.2147/ITT.S91058] [Cited by in Crossref: 37] [Cited by in F6Publishing: 11] [Article Influence: 6.2] [Reference Citation Analysis]
342 Elia D, Torre O, Cassandro R, Caminati A, Harari S. Ultra-rare cystic disease. Eur Respir Rev 2020;29:190163. [DOI: 10.1183/16000617.0163-2019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
343 Haroche J, Cohen-Aubart F, Rollins BJ, Donadieu J, Charlotte F, Idbaih A, Vaglio A, Abdel-Wahab O, Emile JF, Amoura Z. Histiocytoses: emerging neoplasia behind inflammation. Lancet Oncol 2017;18:e113-25. [PMID: 28214412 DOI: 10.1016/S1470-2045(17)30031-1] [Cited by in Crossref: 104] [Cited by in F6Publishing: 46] [Article Influence: 20.8] [Reference Citation Analysis]
344 Özyörük D, Yozgat AK, Kaçar D, Yazal Erdem A, Işık M, Güzelküçük Z, Hacısalihoğlu Ş. Successful treatment of multiple relapsed-refractory Langerhans cell histiocytosis with cyclosporine and review of the literature. Tumori 2021;:3008916211039555. [PMID: 34423687 DOI: 10.1177/03008916211039555] [Reference Citation Analysis]
345 Ozkaya N, Dogan A, Abdel-Wahab O. Identification and Targeting of Kinase Alterations in Histiocytic Neoplasms. Hematol Oncol Clin North Am 2017;31:705-19. [PMID: 28673397 DOI: 10.1016/j.hoc.2017.04.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
346 Chen R, Liu S, Tang L, Yu X, Meng Z, Hu Y, Li J, Liang X. On the knowledge of solitary juvenile xanthogranuloma of the eyelid: a case series and literature review. Graefes Arch Clin Exp Ophthalmol 2022. [PMID: 35084531 DOI: 10.1007/s00417-022-05560-6] [Reference Citation Analysis]
347 Song H, Song JS, Wallace EB, Kaban LB, Huang MS, Kraft S, Mihm MC Jr, Kroshinsky D. A 12-Month-Old Healthy Girl with a New Oral Ulcer and Chronic Diaper Rash. Dermatopathology (Basel) 2017;4:24-30. [PMID: 29456998 DOI: 10.1159/000481308] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
348 Sánchez-romero C, Cuenca Arriaga AI, Paes de Almeida O, Gutiérrez Cortés E. Oral juvenile xanthogranuloma in a child: Clinical, histological and immunohistochemical profile of a rare entity. J Cutan Pathol 2018;45:515-21. [DOI: 10.1111/cup.13152] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
349 Said J. Genomic profiling of histiocytic sarcoma: new insights into pathogenesis and subclassification. Haematologica 2020;105:854-5. [PMID: 32238464 DOI: 10.3324/haematol.2019.246314] [Reference Citation Analysis]
350 Montella L, Ottaviano M, Riccio V, Picozzi F, Facchini G, Insabato L, Giuliano M, Palmieri G. Results of TETimaX Trial of Langerhans Cell Histiocytosis Treatment and Perspectives on the Role of Imatinib Mesylate in the Era of MAPK Signaling. Biomedicines 2021;9:1759. [DOI: 10.3390/biomedicines9121759] [Reference Citation Analysis]
351 Yagasaki H, Watanabe N, Hirai M, Shimozawa K, Mugishima H, Takahashi S. A Japanese infant with systemic juvenile xanthogranuloma mimicking severe microangiopathy. Ann Hematol 2017;96:1233-5. [PMID: 28500427 DOI: 10.1007/s00277-017-3015-9] [Reference Citation Analysis]
352 Kim HM, Yang WI, Lyu CJ, Hahn SM, Yoon SO. Descriptive Analysis of Histiocytic and Dendritic Cell Neoplasms: A Single-Institution Experience. Yonsei Med J 2020;61:774-9. [PMID: 32882761 DOI: 10.3349/ymj.2020.61.9.774] [Reference Citation Analysis]
353 Radzikowska E, Błasińska-Przerwa K, Wiatr E, Bestry I, Langfort R, Roszkowski-Śliż K. Pneumothorax in Patients with Pulmonary Langerhans Cell Histiocytosis. Lung 2018;196:715-20. [PMID: 30187131 DOI: 10.1007/s00408-018-0155-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
354 Ross AB, Davis KW, Buehler D, Chan BY. Primary Rosai-Dorfman Disease of Bone: A Report of Two Cases. Case Rep Radiol 2019;2019:1720131. [PMID: 30719368 DOI: 10.1155/2019/1720131] [Reference Citation Analysis]
355 de Soccio G, Savastano V, Minasi S, Bertin S, Serafini M, Vittori T, Riminucci M, Corsi A. Solitary juvenile xanthogranuloma of the hypopharynx. Clinico-pathologic study in a child with β-Thalassemia Major and Cutaneous Mastocytosis. Int J Pediatr Otorhinolaryngol 2020;135:110088. [PMID: 32505931 DOI: 10.1016/j.ijporl.2020.110088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
356 Shokripour M, Mokhtari M, Samizadeh B. Association of soluble interleukin-2 receptor alpha with laboratory parameters and clinical findings of hemophagocytic lymphohistiocytosis patients: The first report from South of Iran. J Educ Health Promot 2020;9:48. [PMID: 32318616 DOI: 10.4103/jehp.jehp_579_19] [Reference Citation Analysis]
357 Gonzalez MF, Azar A, Jamal SME. Solitary soft tissue Langerhans cell histiocytosis of the neck. Cytohistological correlation and review of the literature. Cytopathology 2018;29:114-7. [PMID: 29159994 DOI: 10.1111/cyt.12499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
358 Popovic A, Naous R, Damron TA. LCH of the Scapula in a 2-Year-Old Masquerading as an ABC: A Case Report and Literature Review. TOORTHJ 2020;14:130-4. [DOI: 10.2174/1874325002014010130] [Reference Citation Analysis]
359 Thurner L, Bewarder M, Rosar F, Orth P, Meuter RB, Rixecker T, Lesan V, Kohn DM, Schneider G, Baumhoer D, Bohle RM, Veith C, Bittenbring JT. Indeterminate Dendritic Cell Tumor With Persistent Complete Metabolic Response to BRAF/MEK Inhibition. Hemasphere 2021;5:e511. [PMID: 33324955 DOI: 10.1097/HS9.0000000000000511] [Reference Citation Analysis]
360 Rossi ED, Pantanowitz L, Hornick JL. Cytologic and histological features of rare nonepithelial and nonlymphoid tumors of the thyroid. Cancer Cytopathol 2021;129:583-602. [PMID: 33493367 DOI: 10.1002/cncy.22404] [Reference Citation Analysis]
361 Kanakis M, Petrou P, Lourida G, Georgalas I. Erdheim-Chester disease: a comprehensive review from the ophthalmologic perspective. Surv Ophthalmol 2021:S0039-6257(21)00137-5. [PMID: 34081930 DOI: 10.1016/j.survophthal.2021.05.013] [Reference Citation Analysis]
362 Zaimi Y, Ayari M, Mensi A, Bel Hadj Kacem L, Achouri L, Bouzrara M, Said Y, Mouelhi L, Debbeche R. Pseudo-Meigs' Syndrome in Tunisian H Syndrome Female Patient: First Case Reported. Appl Clin Genet 2021;14:235-9. [PMID: 33883924 DOI: 10.2147/TACG.S306298] [Reference Citation Analysis]
363 Chakraborty R, Abdel-Wahab O, Durham BH. MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age. Cold Spring Harb Perspect Med 2021;11:a034892. [PMID: 32601132 DOI: 10.1101/cshperspect.a034892] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
364 Wolter NE, Ngan B, Whitlock JA, Dickson BC, Propst EJ. Atypical juvenile histiocytosis with novel KIF5B-ALK gene fusion mimicking subglottic hemangioma. International Journal of Pediatric Otorhinolaryngology 2019;126:109585. [DOI: 10.1016/j.ijporl.2019.07.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
365 Knitza J, Kampylafka E, Wacker J, Schett G, Manger B. Morbus Erdheim-Chester: Eine wichtige Differenzialdiagnose und ihre Leitsymptome. Z Rheumatol 2019;78:66-71. [DOI: 10.1007/s00393-018-0566-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
366 Razanamahery J, Roggy A, Emile JF, Malakhia A, Lakkis Z, Garnache-Ottou F, Soumagne T, Cohen-Aubart F, Haroche J, Bonnotte B. Case Report: Evolution of a Severe Vascular Refractory Form of ECD Requiring Liver Transplantation Correlated With the Change in the Monocyte Subset Analysis. Front Immunol 2021;12:755846. [PMID: 34867991 DOI: 10.3389/fimmu.2021.755846] [Reference Citation Analysis]
367 Hamza A, Zhang Z, Al-Khafaji B. Solitary extranodal Rosai-Dorfman disease of the mandible: an exceedingly rare presentation. Autops Case Rep 2018;8:e2018036. [PMID: 30101140 DOI: 10.4322/acr.2018.036] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
368 Kamili NA, Morrison CE, Bagg A, Westheim A, Hafeez F. Leukemia Cutis With Histopathologic and Immunophenotypic Features Resembling S100-Negative CD1a-Positive Cutaneous Histiocytosis. Am J Dermatopathol 2021;43:574-5. [PMID: 33298709 DOI: 10.1097/DAD.0000000000001868] [Reference Citation Analysis]
369 Farnault L, Hélias-Rodzewicz Z, Venton G, Fanciullino R, Gabriel S, Mescam L, Haroche J, Donadieu J, Emile JF. Response to trametinib of histiocytosis with an activating PTPN11 mutation. Leuk Lymphoma 2020;61:194-7. [PMID: 31393194 DOI: 10.1080/10428194.2019.1650175] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
370 Picarsic J, Jaffe R. Pathology of Histiocytic Disorders and Neoplasms and Related Disorders. In: Abla O, Janka G, editors. Histiocytic Disorders. Cham: Springer International Publishing; 2018. pp. 3-50. [DOI: 10.1007/978-3-319-59632-7_1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
371 Frater JL. The histiocytoses: as easy as ABC (or LCMRH). Blood 2016;127:2655-6. [PMID: 27257174 DOI: 10.1182/blood-2016-03-706267] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
372 White VA. Understanding and Classification of Ocular Lymphomas. Ocul Oncol Pathol 2019;5:379-86. [PMID: 31768360 DOI: 10.1159/000499845] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
373 Difloe-Geisert JC, Bernauer SA, Schneeberger N, Bornstein MM, Walter C. Periodontal manifestations of Langerhans cell histiocytosis: a systematic review. Clin Oral Investig 2021;25:3341-9. [PMID: 33751219 DOI: 10.1007/s00784-021-03873-0] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
374 Bergsten E, Horne A, Hed Myrberg I, Aricó M, Astigarraga I, Ishii E, Janka G, Ladisch S, Lehmberg K, McClain KL, Minkov M, Nanduri V, Rosso DA, Sieni E, Winiarski J, Henter JI. Stem cell transplantation for children with hemophagocytic lymphohistiocytosis: results from the HLH-2004 study. Blood Adv 2020;4:3754-66. [PMID: 32780845 DOI: 10.1182/bloodadvances.2020002101] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
375 Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, Garces JC, Khoury JD, Yin CC. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease. Mod Pathol 2017;30:1367-77. [PMID: 28664935 DOI: 10.1038/modpathol.2017.55] [Cited by in Crossref: 89] [Cited by in F6Publishing: 72] [Article Influence: 17.8] [Reference Citation Analysis]
376 Váradi Z, Bánusz R, Csomor J, Kállay K, Varga E, Kertész G, Csóka M. Effective BRAF inhibitor vemurafenib therapy in a 2-year-old patient with sequentially diagnosed Langerhans cell histiocytosis and Erdheim-Chester disease. Onco Targets Ther 2017;10:521-6. [PMID: 28182116 DOI: 10.2147/OTT.S121615] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
377 Melloul S, Hélias-Rodzewicz Z, Cohen-Aubart F, Charlotte F, Fraitag S, Terrones N, Riller Q, Chazal T, Héritier S, Moreau A, Kambouchner M, Copin MC, Donadieu J, Taly V, Amoura Z, Haroche J, Emile JF. Highly sensitive methods are required to detect mutations in histiocytoses. Haematologica 2019;104:e97-9. [PMID: 30262559 DOI: 10.3324/haematol.2018.201194] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
378 Sung YE, Lee YS, Lee J, Lee KY. Erdheim-Chester Disease Involving Lymph Nodes and Liver Clinically Mimicking Lymphoma: A Case Report. J Pathol Transl Med 2018;52:183-90. [PMID: 29281781 DOI: 10.4132/jptm.2017.10.16] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
379 Lee T, Jung T, Baek H, Kim S, Lee K, Yun SJ. Disseminated juvenile xanthogranuloma occurring after treatment of Langerhans cell histiocytosis: a case report. Childs Nerv Syst 2018;34:765-70. [DOI: 10.1007/s00381-017-3675-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
380 Mcintire PJ, Kilic AI, Chen HH, Atieh M, Wojcik EM, Pambuccian SE. Fine-needle aspiration specimens of 3 cases of intra-abdominal Rosai-Dorfman disease with comprehensive review of the literature. Journal of the American Society of Cytopathology 2019;8:190-205. [DOI: 10.1016/j.jasc.2019.01.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
381 Villatoro-Villar M, Koster MJ. Erdheim-Chester Disease with atrial mass and perinephric calcification. Clin Case Rep. 2017;5:2153-2154. [PMID: 29225878 DOI: 10.1002/ccr3.1258] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
382 Dupeux M, Boccara O, Frassati-biaggi A, Hélias-rodzewicz Z, Leclerc-mercier S, Bodemer C, Molina TJ, Emile J, Fraitag S. Langerhans Cell Histiocytoma: A Benign Histiocytic Neoplasm of Diverse Lines of Terminal Differentiation. The American Journal of Dermatopathology 2019;41:29-36. [DOI: 10.1097/dad.0000000000001255] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
383 Fernández Armenteros JM, Arco Huguet N, Sanmartin Novell V, Vilardell Villellas F, Velasco Sanchez A, Martró Català E, Martí Laborda RM, Soria Gili X. Langerhans cell histiocytosis mimicking molluscum contagiosum: A case series. Pediatr Blood Cancer 2018;65:e27047. [DOI: 10.1002/pbc.27047] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
384 Joo JW, Chung T, Cho YA, Kim SK. Recurrent Indeterminate Dendritic Cell Tumor of the Skin. J Pathol Transl Med 2018;52:243-7. [PMID: 29621879 DOI: 10.4132/jptm.2018.03.27] [Reference Citation Analysis]
385 Bansal AG, Rosenberg HK. Sonography of pediatric superficial lumps and bumps: illustrative examples from head to toe. Pediatr Radiol 2017;47:1171-83. [PMID: 28779193 DOI: 10.1007/s00247-017-3859-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
386 Kazlouskaya V, Khan N, Heilman E. Scleromyxedema histopathologically mimicking hypercellular fibrous papules (angiofibomas): Case report of an unusual histopathological presentation. J Cutan Pathol 2020;47:638-42. [PMID: 32048744 DOI: 10.1111/cup.13665] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
387 Setiadi A, Zoref-lorenz A, Lee CY, Jordan MB, Chen LYC. Malignancy-associated haemophagocytic lymphohistiocytosis. The Lancet Haematology 2022. [DOI: 10.1016/s2352-3026(21)00366-5] [Reference Citation Analysis]
388 Ramgopal A, Segal J, Mukhtar S, Yu J, Picarsic J, Tersak JM, Allen SW. A chronic eyelid lesion in a child: multi-disciplinary approach to diagnosis, treatment and management of a highly atypical histiocytic lesion. Pediatr Hematol Oncol 2021;:1-7. [PMID: 34379045 DOI: 10.1080/08880018.2021.1960657] [Reference Citation Analysis]
389 Papo M, Corneau A, Cohen-Aubart F, Robin B, Emile JF, Miyara M, Blanc C, Amoura Z, Hermine O, Haroche J, Trovati Maciel T. Immune phenotyping of Erdheim-Chester disease through mass cytometry highlights decreased proportion of non-classical monocytes and increased proportion of Th17 cells. Ann Rheum Dis 2020;79:1522-4. [PMID: 32424030 DOI: 10.1136/annrheumdis-2020-217316] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
390 Michon A, Cohen Aubart F, Haroche J, Charlotte F, Maksud P, Amoura Z. Long-bones involvement in generalized crystal-storing histiocytosis. Joint Bone Spine 2019;86:652-3. [PMID: 30685538 DOI: 10.1016/j.jbspin.2019.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
391 Ajabnoor R, Bell PD, Schiffman S, Carmody E, Monu J, Wang X. Histiocytic Sarcoma Arising From a Long Bone: Report of Two Cases. Int J Surg Pathol 2021;29:752-8. [PMID: 33750231 DOI: 10.1177/1066896921996464] [Reference Citation Analysis]
392 Bonnet P, Chasset F, Moguelet P, Abisror N, Itzykson R, Bouaziz JD, Hirsch P, Barbaud A, Haroche J, Mekinian A, Hélias-Rodzewicz Z, Clappier E, Fenaux P, Fain O, Tazi A, Emile JF; MINHEMON and EMSED. Erdheim-Chester disease associated with chronic myelomonocytic leukemia harboring the same clonal mutation. Haematologica 2019;104:e530-3. [PMID: 31221777 DOI: 10.3324/haematol.2019.223552] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
393 Xu X, Luo Z, Song H, Xu W, Henter J, Zhao N, Wu M, Tang Y. Simple Evaluation of Clinical Situation and Subtypes of Pediatric Hemophagocytic Lymphohistiocytosis by Cytokine Patterns. Front Immunol 2022;13:850443. [DOI: 10.3389/fimmu.2022.850443] [Reference Citation Analysis]
394 Garonzi C, Chinello M, Cesaro S. Emapalumab for adult and pediatric patients with hemophagocytic lymphohistiocytosis. Expert Rev Clin Pharmacol 2021;14:527-34. [PMID: 33686916 DOI: 10.1080/17512433.2021.1901576] [Reference Citation Analysis]
395 Miyashita T, Yamazaki S, Ohta H, Nakamura H, Nagata M. Secondary pulmonary hypertension due to pulmonary Langerhans cell histiocytosis accompanied with panhypopituitarism. Respirol Case Rep 2021;9:e00697. [PMID: 33304595 DOI: 10.1002/rcr2.697] [Reference Citation Analysis]
396 Héritier S, Barkaoui M, Miron J, Thomas C, Moshous D, Lambilliotte A, Mazingue F, Kebaili K, Jeziorski E, Plat G, Aladjidi N, Pacquement H, Galambrun C, Brugières L, Leverger G, Mansuy L, Paillard C, Deville A, Pagnier A, Lutun A, Gillibert-yvert M, Stephan J, Cohen-aubart F, Haroche J, Pellier I, Millot F, Gandemer V, Martin-duverneuil N, Taly V, Hélias-rodzewicz Z, Emile J, Hoang-xuan K, Idbaih A, Donadieu J. Incidence and risk factors for clinical neurodegenerative Langerhans cell histiocytosis: a longitudinal cohort study. Br J Haematol 2018;183:608-17. [DOI: 10.1111/bjh.15577] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
397 Horna P, Shao H, Idrees A, Glass LF, Torres-Cabala CA. Indeterminate dendritic cell neoplasm of the skin: A 2-case report and review of the literature. J Cutan Pathol 2017;44:958-63. [PMID: 28880462 DOI: 10.1111/cup.13017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
398 Hunjan MK, Anyasodor MC, Hock YL, Mehta A. An unusual case of progressive nodular histiocytosis. Int J Dermatol 2021. [PMID: 34473852 DOI: 10.1111/ijd.15886] [Reference Citation Analysis]
399 Corominas H, Badlissi F. New classification of histiocytosis. Med Clin (Barc) 2018;150:123. [PMID: 28919209 DOI: 10.1016/j.medcli.2017.06.071] [Reference Citation Analysis]
400 Tantawy AAG, Ragab IA, Elsherif NHK, Makkeyah SM, AbdelRaheem HG, Elsantiel HIE. Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates. Pediatr Hematol Oncol 2020;37:696-706. [PMID: 32706277 DOI: 10.1080/08880018.2020.1790703] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
401 Choi MB, Salomão DR, Smith WM, Pulido JS, Garrity JA. Ophthalmic Findings of Rosai-Dorfman Disease. Am J Ophthalmol 2018;188:164-72. [PMID: 29428455 DOI: 10.1016/j.ajo.2018.01.037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
402 Kumar V, Eulitt PJ, Bermudez A, Khagi S. Hemophagocytic lymphohistiocytosis in a patient with glioblastoma: a case report. CNS Oncol 2019;8:CNS45. [PMID: 31777271 DOI: 10.2217/cns-2019-0013] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
403 Fararjeh AS, Liu YN. ZBTB46, SPDEF, and ETV6: Novel Potential Biomarkers and Therapeutic Targets in Castration-Resistant Prostate Cancer. Int J Mol Sci 2019;20:E2802. [PMID: 31181727 DOI: 10.3390/ijms20112802] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
404 Quint KD, Cleven AH, Vermeer MH. Special variant of histiocytosis. BMJ Case Rep 2017;2017:bcr-2017-221538. [PMID: 29070620 DOI: 10.1136/bcr-2017-221538] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
405 Durham BH, Roos-Weil D, Baillou C, Cohen-Aubart F, Yoshimi A, Miyara M, Papo M, Hélias-Rodzewicz Z, Terrones N, Ozkaya N, Dogan A, Rampal R, Urbain F, Le Fèvre L, Diamond EL, Park CY, Papo T, Charlotte F, Gorochov G, Taly V, Bernard OA, Amoura Z, Abdel-Wahab O, Lemoine FM, Haroche J, Emile JF. Functional evidence for derivation of systemic histiocytic neoplasms from hematopoietic stem/progenitor cells. Blood 2017;130:176-80. [PMID: 28566492 DOI: 10.1182/blood-2016-12-757377] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 9.6] [Reference Citation Analysis]
406 Flores-Terry MA, Sanz-Trenado JL, García-Arpa M, Cortina-de la Calle MP. Cutaneous Langerhans Cell Histiocytosis Presenting in Adulthood. Actas Dermosifiliogr (Engl Ed) 2019;110:167-9. [PMID: 30270145 DOI: 10.1016/j.ad.2017.12.015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
407 Kanvinde P, Vp K, Ganatra P, Swami A, Shah N, Desai M, Agarwal B, Bodhanwala M, Mudaliar S. Targeted therapy with BRAF inhibitor Vemurafenib in relapse/refractory multisystem langerhans cell-retrospective analysis from a tertiary care center in India. Pediatric Hematology Oncology Journal 2021;6:198-200. [DOI: 10.1016/j.phoj.2021.11.004] [Reference Citation Analysis]
408 El Sissy FN, Verkarre V, Larousserie F, Thiounn N, Haroche J, Emile JF. [Pelvic mass in 70 years old patient: Difficult diagnosis of Erdheim-Chester disease]. Ann Pathol 2021:S0242-6498(21)00262-5. [PMID: 34969554 DOI: 10.1016/j.annpat.2021.12.003] [Reference Citation Analysis]
409 Díaz Del Arco C, Ortega Medina L, Fernández Aceñero MJ. [Histiocytic and dendritic cell neoplasms: Review of the literature]. Rev Esp Patol 2018;51:160-9. [PMID: 30012309 DOI: 10.1016/j.patol.2017.10.006] [Reference Citation Analysis]
410 Minoia F, Bovis F, Davì S, Insalaco A, Lehmberg K, Shenoi S, Weitzman S, Espada G, Gao Y, Anton J, Kitoh T, Kasapcopur O, Sanner H, Merino R, Astigarraga I, Alessio M, Jeng M, Chasnyk V, Nichols KE, Huasong Z, Li C, Micalizzi C, Ruperto N, Martini A, Cron RQ, Ravelli A, Horne A, Abinun M, Aggarwal A, Akikusa J, Al-mayouf S, Alessio M, Anton J, Apaz MT, Astigarraga I, Avcin T, Ayaz NA, Barone P, Bica B, Bolt I, Bovis F, Breda L, Chasnyk V, Cimaz R, Corona F, Cron RQ, Cuttica R, Davì S, Davidsone Z, De Cunto C, De Inocencio J, Demirkaya E, Eisenstein EM, Enciso S, Espada G, Fischbach M, Frosch M, Gallizzi R, Gamir ML, Gao Y, Griffin T, Grom A, Hashad S, Hennon T, Henter J, Horne A, Horneff G, Huasong Z, Huber A, Ilowite N, Insalaco A, Ioseliani M, Jeng M, Kapović AM, Kasapcopur O, Khubchandani R, Kitoh T, Koné-paut I, de Oliveira SKF, Lattanzi B, Lehmberg K, Lepore L, Li C, Lipton JM, Magni-manzoni S, Maritsi D, Martini A, Mccurdy D, Merino R, Micalizzi C, Miettunen P, Minoia F, Mulaosmanovic V, Nichols KE, Nielsen S, Ozen S, Pal P, Prahalad S, Ravelli A, Rigante D, Rumba-rozenfelde I, Ruperto N, Russo R, Magalhães CS, Sanner H, Sewairi WMS, Shenoi S, Artur Silva C, Stanevicha V, Sterba G, Stine KC, Susic G, Sztajnbok F, Takei S, Trauzeddel R, Tsitsami E, Unsal E, Uziel Y, Vougiouka O, Wallace CA, Weaver L, E. Weiss J, Weitzman S, Wouters C, Wulffraat N, Zletni M, Arico M, Egeler RM, Filipovich AH, Gadner H, Imashuku S, Janka G, Ladisch S, Mcclain KL, Webb D. Development and Initial Validation of the Macrophage Activation Syndrome/Primary Hemophagocytic Lymphohistiocytosis Score, a Diagnostic Tool that Differentiates Primary Hemophagocytic Lymphohistiocytosis from Macrophage Activation Syndrome. The Journal of Pediatrics 2017;189:72-78.e3. [DOI: 10.1016/j.jpeds.2017.06.005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 21] [Article Influence: 6.6] [Reference Citation Analysis]
411 Valera ET, Brassesco MS, Reis MBFD, Maggioni G, Guerino-Cunha RL, Grecco CE, Jr JE, Kato M, Tone LG. Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child: Is it time to consider new targets? Pediatr Hematol Oncol 2021;38:89-96. [PMID: 32897114 DOI: 10.1080/08880018.2020.1811438] [Reference Citation Analysis]
412 Baig A, Albrecht S, Corredor AG, Fiset PO, Chen MF. Unique Case of Congenital Langerhans Cell Histiocytosis Presenting as Intrauterine Fetal Demise. Pediatr Dev Pathol 2022;:10935266221078501. [PMID: 35421319 DOI: 10.1177/10935266221078501] [Reference Citation Analysis]
413 Razanamahery J, Diamond EL, Cohen-Aubart F, Plate KH, Lourida G, Charlotte F, Hélias-Rodzewicz Z, Goyal G, Go RS, Dogan A, Abdel-Wahab O, Durham B, Ozkaya N, Amoura Z, Emile JF, Haroche J. Erdheim-Chester disease with concomitant Rosai-Dorfman like lesions: a distinct entity mainly driven by MAP2K1. Haematologica 2020;105:e5-8. [PMID: 31123032 DOI: 10.3324/haematol.2019.216937] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
414 Berti A, Cavalli G, Guglielmi B, Biavasco R, Campochiaro C, Tomelleri A, Nicoletti R, Panzacchi A, Ferrarini M, Dagna L. Tocilizumab in patients with multisystem Erdheim-Chester disease. Oncoimmunology 2017;6:e1318237. [PMID: 28680751 DOI: 10.1080/2162402X.2017.1318237] [Cited by in Crossref: 18] [Cited by in F6Publishing: 8] [Article Influence: 3.6] [Reference Citation Analysis]
415 Machado I, Columbie A, Nieto Morales G, Forteza-Suarez M, Renó Céspedes JLS, Marhuenda Fluixa A, Llombart-Bosch A. [Bone and soft tissue Langerhans cell histiocytosis with multinucleated giant cells and BRAF V600E mutation]. Rev Esp Patol 2021;54:136-40. [PMID: 33726891 DOI: 10.1016/j.patol.2018.08.003] [Reference Citation Analysis]
416 Fathala A, Edathodu J, Bakshi N. FDG PET/CT in the Evaluation of a Rare Case of Multisystem Involvement in Newly Diagnosed Rosai-Dorfman-Destombes Disease. Saudi J Med Med Sci 2021;9:195-8. [PMID: 34084112 DOI: 10.4103/sjmms.sjmms_99_20] [Reference Citation Analysis]
417 Birndt S, Schenk T, Heinevetter B, Brunkhorst FM, Maschmeyer G, Rothmann F, Weber T, Müller M, Panse J, Penack O, Schroers R, Braess J, Frickhofen N, Ehl S, Janka G, Lehmberg K, Pletz MW, Hochhaus A, Ernst T, La Rosée P. Hemophagocytic lymphohistiocytosis in adults: collaborative analysis of 137 cases of a nationwide German registry. J Cancer Res Clin Oncol 2020;146:1065-77. [PMID: 32076823 DOI: 10.1007/s00432-020-03139-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 12.0] [Reference Citation Analysis]
418 Janku F, Diamond EL, Goodman AM, Raghavan VK, Barnes TG, Kato S, Abdel-Wahab O, Durham BH, Meric-Bernstam F, Kurzrock R. Molecular Profiling of Tumor Tissue and Plasma Cell-Free DNA from Patients with Non-Langerhans Cell Histiocytosis. Mol Cancer Ther 2019;18:1149-57. [PMID: 31015311 DOI: 10.1158/1535-7163.MCT-18-1244] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
419 Durham BH. Molecular characterization of the histiocytoses: Neoplasia of dendritic cells and macrophages. Seminars in Cell & Developmental Biology 2019;86:62-76. [DOI: 10.1016/j.semcdb.2018.03.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 10.7] [Reference Citation Analysis]
420 Halbritter F, Farlik M, Schwentner R, Jug G, Fortelny N, Schnöller T, Pisa H, Schuster LC, Reinprecht A, Czech T, Gojo J, Holter W, Minkov M, Bauer WM, Simonitsch-Klupp I, Bock C, Hutter C. Epigenomics and Single-Cell Sequencing Define a Developmental Hierarchy in Langerhans Cell Histiocytosis. Cancer Discov 2019;9:1406-21. [PMID: 31345789 DOI: 10.1158/2159-8290.CD-19-0138] [Cited by in Crossref: 18] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
421 Liu DJ, Rullo J, Kratky V, Farmer J. Histiocytic sarcoma of the eyelid. Saudi J Ophthalmol 2019;33:300-3. [PMID: 31686975 DOI: 10.1016/j.sjopt.2019.07.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
422 Alkatan HM, Alzahem TA, Maktabi AMY. Ophthalmic histiocytic lesions: a baseline demographic and clinicopathological study of 28 cases from two eye centers. Int Ophthalmol 2021. [PMID: 34727265 DOI: 10.1007/s10792-021-02108-1] [Reference Citation Analysis]
423 Murakami N, Sakai T, Arai E, Muramatsu H, Ichikawa D, Asai S, Shimoyama Y, Ishiguro N, Takahashi Y, Okuno Y, Nishida Y. Targetable driver mutations in multicentric reticulohistiocytosis. Haematologica 2020;105:e61-4. [PMID: 31171640 DOI: 10.3324/haematol.2019.218735] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
424 Alzahem TA, Cruz AA, Maktabi AMY, Chahud F, Alkatan H. Ophthalmic Rosai-Dorfman disease: a multi-centre comprehensive study. BMC Ophthalmol 2021;21:404. [PMID: 34814862 DOI: 10.1186/s12886-021-02173-1] [Reference Citation Analysis]
425 Huang R, Hayashi Y, Yan X, Bu J, Wang J, Zhang Y, Zhou Y, Tang Y, Wu L, Xu Z, Liu X, Wang Q, Zhou J, Xiao Z, Bridges JP, Marsh RA, Zhang K, Jordan MB, Li Y, Huang G. HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis. Haematologica 2017;102:1956-68. [PMID: 28860338 DOI: 10.3324/haematol.2017.174979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
426 Zhao M, Tang L, Sun S, Cui J, Chen H. Radiologic findings that aid in the reduction of misdiagnoses of Langerhans cell histiocytosis of the bone: a retrospective study. World J Surg Oncol 2021;19:146. [PMID: 33971894 DOI: 10.1186/s12957-021-02261-y] [Reference Citation Analysis]
427 Estrada-Veras JI, O'Brien KJ, Boyd LC, Dave RH, Durham B, Xi L, Malayeri AA, Chen MY, Gardner PJ, Alvarado-Enriquez JR, Shah N, Abdel-Wahab O, Gochuico BR, Raffeld M, Jaffe ES, Gahl WA. The clinical spectrum of Erdheim-Chester disease: an observational cohort study. Blood Adv 2017;1:357-66. [PMID: 28553668 DOI: 10.1182/bloodadvances.2016001784] [Cited by in Crossref: 83] [Cited by in F6Publishing: 71] [Article Influence: 16.6] [Reference Citation Analysis]
428 Sharma A, McAfee J, Wang L, Cook E, Ababneh E, Bergfeld WF. Utility of Cyclin D1 Immunostaining in Cutaneous Xanthogranuloma. Am J Dermatopathol 2021;43:e141-5. [PMID: 34797805 DOI: 10.1097/DAD.0000000000002060] [Reference Citation Analysis]
429 Barkaoui M, Queheille E, Aladjidi N, Plat G, Jeziorski E, Moshous D, Lambilliotte A, Kebaili K, Pacquement H, Leverger G, Mansuy L, Entz‐werlé N, Bodet D, Schneider P, Pagnier A, Lutun A, Gillibert‐yvert M, Millot F, Toutain F, Reguerre Y, Thomas C, Tazi A, Emile J, Donadieu J, Héritier S. Long‐term follow‐up of children with risk organ‐negative Langerhans cell histiocytosis after 2‐chlorodeoxyadenosine treatment. Br J Haematol 2020;191:825-34. [DOI: 10.1111/bjh.16944] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
430 Miller PG, Sperling AS, Gibson CJ, Viswanathan K, Castellano C, McConkey M, Ceremsak J, Taylor MS, Birndt S, Perner F, Arnason J, Agrawal M, Schram AM, Nikiforow S, Pihan G, Hasserjian RP, Aster JC, La Rosée P, Morgan EA, Berliner N, Ebert BL. Contribution of clonal hematopoiesis to adult-onset hemophagocytic lymphohistiocytosis. Blood 2020;136:3051-5. [PMID: 32961550 DOI: 10.1182/blood.2020008206] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
431 Gorodetskiy VR, Klapper W, Probatova NA, Vasilyev VI, Rozhnova EV. Simultaneous Occurrence of Rosai-Dorfman Disease and Nodal Marginal Zone Lymphoma in a Patient with Sjögren's Syndrome. Case Rep Hematol 2018;2018:7930823. [PMID: 30305966 DOI: 10.1155/2018/7930823] [Reference Citation Analysis]
432 Salunke B, Savarkar S, Patil VP. Hemophagocytic Syndrome-An Approach to the Management. Indian J Crit Care Med 2019;23:S191-6. [PMID: 31656377 DOI: 10.5005/jp-journals-10071-23251] [Reference Citation Analysis]
433 Bąbol-Pokora K, Wołowiec M, Popko K, Jaworowska A, Bryceson YT, Tesi B, Henter JI, Młynarski W, Badowska W, Balwierz W, Drabko K, Kałwak K, Maciejka-Kembłowska L, Pieczonka A, Sobol-Milejska G, Kołtan S, Malinowska I; Polish Pediatric Hematology, Oncology Society. Molecular Genetics Diversity of Primary Hemophagocytic Lymphohistiocytosis among Polish Pediatric Patients. Arch Immunol Ther Exp (Warsz) 2021;69:31. [PMID: 34677667 DOI: 10.1007/s00005-021-00635-4] [Reference Citation Analysis]
434 Kim J, Steeples LR, Jones NP. Ocular Involvement in the Histiocytoses: A Literature Review with an Illustrative Case Series. Ocul Immunol Inflamm 2021;:1-15. [PMID: 34637661 DOI: 10.1080/09273948.2021.1936566] [Reference Citation Analysis]
435 Bloom JL, Lin C, Imundo L, Guthery S, Stepenaskie S, Galambos C, Lowichik A, Bohnsack JF. H syndrome: 5 new cases from the United States with novel features and responses to therapy. Pediatr Rheumatol Online J 2017;15:76. [PMID: 29041934 DOI: 10.1186/s12969-017-0204-y] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 6.0] [Reference Citation Analysis]
436 Cohen Aubart F, Idbaih A, Galanaud D, Law-Ye B, Emile JF, Charlotte F, Donadieu J, Maksud P, Seilhean D, Amoura Z, Hoang-Xuan K, Haroche J. Central nervous system involvement in Erdheim-Chester disease: An observational cohort study. Neurology 2020;95:e2746-54. [PMID: 32887776 DOI: 10.1212/WNL.0000000000010748] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
437 Zanelli M, Smith M, Mengoli MC, Spaggiari L, De Marco L, Lococo F, Puma F, Ascani S. Erdheim-Chester disease: description of two illustrative cases involving the lung. Histopathology 2018;73:167-72. [PMID: 29469219 DOI: 10.1111/his.13501] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
438 Young JR, Johnson GB, Murphy RC, Go RS, Broski SM. 18F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker. J Nucl Med 2018;59:774-9. [PMID: 29097410 DOI: 10.2967/jnumed.117.200741] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 4.6] [Reference Citation Analysis]
439 Tazi A, Lorillon G, Haroche J, Neel A, Dominique S, Aouba A, Bouaziz JD, de Margerie-Melon C, Bugnet E, Cottin V, Comont T, Lavigne C, Kahn JE, Donadieu J, Chevret S. Vinblastine chemotherapy in adult patients with langerhans cell histiocytosis: a multicenter retrospective study. Orphanet J Rare Dis. 2017;12:95. [PMID: 28532436 DOI: 10.1186/s13023-017-0651-z] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
440 Fatobene G, Haroche J, Hélias-Rodzwicz Z, Charlotte F, Taly V, Ferreira AM, Abdo ANR, Rocha V, Emile JF. BRAF V600E mutation detected in a case of Rosai-Dorfman disease. Haematologica 2018;103:e377-9. [PMID: 29748446 DOI: 10.3324/haematol.2018.190934] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
441 Alshagroud R, Alharbi H, Caplash J, Merzianu M, Aguirre A. Lip mass. J Am Dent Assoc 2018;149:650-4. [PMID: 29731107 DOI: 10.1016/j.adaj.2018.03.020] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
442 Fernández-Eulate G, Muñoz-Lopetegi A, Ruiz I, Urtasun M. Vemurafenib as first-line therapy in BRAF-V600E-mutant Erdheim-Chester disease with CNS involvement. BMJ Case Rep 2019;12:e228280. [PMID: 31748352 DOI: 10.1136/bcr-2018-228280] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
443 Marguet F, Piton N, Adle-Biassette H, Renaud F, Bohers E, Boyer T, Zarea A, Derrey S, Sabourin JC, Laquerrière A. Molecular characteristics of multifocal brain histiocytic sarcoma. Neuropathol Appl Neurobiol 2019;45:309-13. [PMID: 29679510 DOI: 10.1111/nan.12490] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
444 Zhang Y, Chen H, Jiang YQ, Xu XL, Zhang W, Zeng XS, Sun JF. Clinicopathological features of cutaneous Rosai-Dorfman disease and its relationship to IgG4-related disease: a retrospective study. Br J Dermatol 2019;181:844-5. [PMID: 30920643 DOI: 10.1111/bjd.17939] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
445 Salari B, Dehner LP. Juvenile and adult xanthogranuloma: A 30-year single-center experience and review of the disorder and its relationship to other histiocytoses. Annals of Diagnostic Pathology 2022;58:151940. [DOI: 10.1016/j.anndiagpath.2022.151940] [Reference Citation Analysis]
446 Prayogo RL, Rahmayunita G, Agustin T, Sirait SP, Arisanty R. Purpuric nail striae as the initial manifestation in multisystem Langerhans cell histiocytosis. Pediatr Dermatol 2020;37:180-3. [PMID: 31697424 DOI: 10.1111/pde.14054] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
447 Goto K, Yoshikawa S, Kiyohara Y, Kukita Y, Miura K, Oishi T. Co-existence of BRAF V600E-mutated malignant melanoma and BRAF V600E-mutated Langerhans cell histiocytosis: A case report. J Cutan Pathol 2021. [PMID: 34792818 DOI: 10.1111/cup.14171] [Reference Citation Analysis]
448 Georgin-Lavialle S, Fayand A, Rodrigues F, Bachmeyer C, Savey L, Grateau G. Autoinflammatory diseases: State of the art. Presse Med 2019;48:e25-48. [PMID: 30686513 DOI: 10.1016/j.lpm.2018.12.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
449 Allen CE, Merad M, McClain KL. Langerhans-Cell Histiocytosis. N Engl J Med. 2018;379:856-868. [PMID: 30157397 DOI: 10.1056/nejmra1607548] [Cited by in Crossref: 125] [Cited by in F6Publishing: 57] [Article Influence: 31.3] [Reference Citation Analysis]
450 Nann D, Schneckenburger P, Steinhilber J, Metzler G, Beschorner R, Schwarze CP, Lang P, Handgretinger R, Fend F, Ebinger M, Bonzheim I. Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae. Ann Hematol 2019;98:1617-26. [DOI: 10.1007/s00277-019-03678-y] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
451 Logan IT, Logan RA. The color of skin: yellow diseases of the skin, nails, and mucosa. Clin Dermatol 2019;37:580-90. [PMID: 31896411 DOI: 10.1016/j.clindermatol.2019.07.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
452 Hazim AZ, Ruan GJ, Hu M, Ravindran A, Rech KL, Young JR, Cox CW, Abeykoon JP, Scheckel C, Vassallo R, Ryu JH, Tobin WO, Koster MJ, Bennani NN, Shah MV, Goyal G, Go RS; Mayo Clinic-University of Alabama at Birmingham Histiocytosis Working Group. Langerhans cell histiocytosis with lung involvement in isolation and multisystem disease: Staging, natural history, and comparative survival. Am J Hematol 2021. [PMID: 34553412 DOI: 10.1002/ajh.26355] [Reference Citation Analysis]
453 Bellalah A, Korbi I, Ben Hammouda S, Achour A, Ben Abdeljelil N, Njima M, Daldoul A, Hadhri R, Njim L, Zakhama A. Small bowel and lung histiocytic sarcoma revealed by acute peritonitis: A case report with review of literature. Ann Med Surg (Lond) 2021;68:102638. [PMID: 34381610 DOI: 10.1016/j.amsu.2021.102638] [Reference Citation Analysis]
454 Ren Q, Chan KW, Huang H, Wang Z, Fang X, Guo C, Li F, Zhang L, Yao Y, Chen Z, Tian Y, Lin T. Platelet-derived alpha-granules are associated with inflammation in patients with NK/T-cell lymphoma-associated hemophagocytic syndrome. Cytokine 2020;126:154878. [PMID: 31739215 DOI: 10.1016/j.cyto.2019.154878] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
455 Bonometti A, Bagnoli F, Fanoni D, Venegoni L, Corti L, Bianchi P, Elli EM, Isimbaldi G, L'Imperio V, Nazzaro G, Passoni E, Berti E. JAK2-mutated Langerhans cell histiocytosis associated with primary myelofibrosis treated with ruxolitinib. Hum Pathol 2018;73:171-5. [PMID: 29107666 DOI: 10.1016/j.humpath.2017.10.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
456 Hashmi H, Murray D, Greenwell J, Shaikh M, Basu S, Krem M. A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge. Case Rep Hematol 2018;2018:7865325. [PMID: 29888013 DOI: 10.1155/2018/7865325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
457 Fusco N, Bonometti A, Augello C, Fabris S, Boiocchi L, Fiori S, Morotti D, Fracchiolla N, Berti E, Gianelli U. Clonal reticulohistiocytosis of the skin and bone marrow associated with systemic mastocytosis and acute myeloid leukaemia. Histopathology 2017;70:1000-8. [PMID: 28074480 DOI: 10.1111/his.13166] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
458 Chang KTE, Tay AZE, Kuick CH, Chen H, Algar E, Taubenheim N, Campbell J, Mechinaud F, Campbell M, Super L, Chantranuwat C, Yuen ST, Chan JKC, Chow CW. ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion. Mod Pathol 2019;32:598-608. [DOI: 10.1038/s41379-018-0168-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
459 Griffin G, Shenoi S, Hughes GC. Hemophagocytic lymphohistiocytosis: An update on pathogenesis, diagnosis, and therapy. Best Pract Res Clin Rheumatol 2020;34:101515. [PMID: 32387063 DOI: 10.1016/j.berh.2020.101515] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
460 Johnstone K, Tsikleas G, Pool L, Barksdale S. S100/CD1a positive dermal infiltrate as an initial presentation of chronic myelomonocytic leukaemia. Pathology 2016;48:628-31. [PMID: 27569552 DOI: 10.1016/j.pathol.2016.06.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
461 Luz J, Zweifel D, Hüllner M, Bühler M, Rücker M, Stadlinger B. Oral manifestation of Langerhans cell histiocytosis: a case report. BMC Oral Health 2018;18:106. [PMID: 29884166 DOI: 10.1186/s12903-018-0568-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
462 Lorillon G, Tazi A. How I manage pulmonary Langerhans cell histiocytosis. Eur Respir Rev. 2017;26. [PMID: 28877978 DOI: 10.1183/16000617.0070-2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 16] [Article Influence: 4.6] [Reference Citation Analysis]
463 Chouk H, Ben Rejeb M, Boussofara L, Elmabrouk H, Ghariani N, Sriha B, Saad A, H'Mida D, Denguezli M. Phenotypic intrafamilial variability including H syndrome and Rosai-Dorfman disease associated with the same c.1088G > A mutation in the SLC29A3 gene. Hum Genomics 2021;15:63. [PMID: 34657628 DOI: 10.1186/s40246-021-00362-z] [Reference Citation Analysis]
464 Choraria A, Andrei V, Rajakulasingam R, Saifuddin A. Musculoskeletal imaging features of non-Langerhans cell histiocytoses. Skeletal Radiol 2021;50:1921-40. [PMID: 33787962 DOI: 10.1007/s00256-021-03765-0] [Reference Citation Analysis]
465 Otrock ZK, Hock KG, Riley SB, de Witte T, Eby CS, Scott MG. Elevated serum ferritin is not specific for hemophagocytic lymphohistiocytosis. Ann Hematol 2017;96:1667-72. [PMID: 28762079 DOI: 10.1007/s00277-017-3072-0] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 5.6] [Reference Citation Analysis]
466 Janeczko-czarnecka M, Raciborska A, Gos M, Kordowska O, Gajek K, Rybka B, Ryczan-krawczyk R, Kałwak K, Ussowicz M. Successful Salvage Treosulfan-Based Megachemotherapy With Allogeneic Stem Cell Transplantation in Nonsyndromic, Therapy-Resistant Disseminated Juvenile Xanthogranuloma: A Case Report. Transplantation Proceedings 2020;52:2844-8. [DOI: 10.1016/j.transproceed.2020.05.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
467 Rajasekhar R, Karthigeyan M, Salunke P, Gupta K. A novel fixation technique using anterior C1 screw in a pediatric solitary cervical spinal juvenile xanthogranuloma. Eur Spine J 2019;28:56-60. [PMID: 30771048 DOI: 10.1007/s00586-019-05915-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
468 Sosnowska P, Antosik P, Ostałowska A, Nogal P, Mańkowski P. Isolated endobronchial juvenile xanthogranuloma: a case report. Contemp Oncol (Pozn) 2020;24:200-2. [PMID: 33235547 DOI: 10.5114/wo.2020.97636] [Reference Citation Analysis]
469 Pawińska-Wa Sikowska K, Cwiklinska M, Wyrobek E, Balwierz W, Bukowska-Strakova K, Dluzniewska A, Gozdzik J, Drabik G, Rygielska M, Stepien K, Skoczen S. Disseminated Juvenile Xanthogranuloma and Hemophagocytic Lymphohistiocytosis Developed During Treatment of Acute Lymphoblastic Leukemia: Case Report. Front Oncol 2020;10:921. [PMID: 32719740 DOI: 10.3389/fonc.2020.00921] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
470 Zhang J, Wang C, Lin C, Bai B, Ye M, Xiang D, Li Z. Spontaneous Thyroid Hemorrhage Caused by Langerhans Cell Histiocytosis: A Case Report and Literature Review. Front Endocrinol (Lausanne) 2021;12:610573. [PMID: 34093427 DOI: 10.3389/fendo.2021.610573] [Reference Citation Analysis]
471 Zinn DJ, Grimes AB, Lin H, Eckstein O, Allen CE, McClain KL. Hydroxyurea: a new old therapy for Langerhans cell histiocytosis. Blood 2016;128:2462-5. [PMID: 27688802 DOI: 10.1182/blood-2016-06-721993] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
472 Pizzi M, Sbaraglia M, De Bartolo D, Dal Santo L, Santoro L, Faedo A, Cecchetto M, Dei Tos AP. Beware of Histiocytes: Whipple Adenopathy and its Mimics. Int J Surg Pathol 2021;:10668969211026370. [PMID: 34142878 DOI: 10.1177/10668969211026370] [Reference Citation Analysis]
473 Sabrine M, Marouen BR, Riahi I, Karima Z, Nadia Z, Issam Z. A pathologic mandibular fracture revealing a bifocal location of Langerhans cell histiocytosis. Ann Med Surg (Lond) 2020;56:128-32. [PMID: 32637087 DOI: 10.1016/j.amsu.2020.06.019] [Reference Citation Analysis]
474 Pucar D, Laskin WB, Saperstein L. Isolated Multinodular Soft-Tissue Rosai-Dorfman Disease on FDG PET/CT. Clin Nucl Med 2018;43:e53-5. [PMID: 29215410 DOI: 10.1097/RLU.0000000000001921] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 1.8] [Reference Citation Analysis]
475 Tregnago AC, Morbeck DL, D’almeida Costa F, Campos AHJFM, Soares FA, Vassallo J. Inflammatory pseudotumor-like follicular dendritic cell tumor: an underdiagnosed neoplasia. Appl Cancer Res 2017;37. [DOI: 10.1186/s41241-017-0051-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
476 d'Amore ESG, Mainardi C, Mussolin L, Carraro E, Alaggio R, Lazzari E, Fusetti S, Ghirotto C, Marzollo A, Biddeci G, Toffolutti T, Massano D, Scarzello G, Zuliani M, Putti MC, Biffi A, Pillon M. Histiocytic sarcoma arising in a child affected by Burkitt lymphoma, with t(8;14)(q24;q32) positivity in both tumors. Pediatr Hematol Oncol 2021;38:1-7. [PMID: 33621154 DOI: 10.1080/08880018.2020.1871452] [Reference Citation Analysis]
477 Mori S, Adar T, Kazlouskaya V, Alexander JB, Heilman E, Glick SA. Cutaneous Langerhans cell histiocytosis presenting with hypopigmented lesions: Report of two cases and review of literature. Pediatr Dermatol 2018;35:502-6. [PMID: 29691886 DOI: 10.1111/pde.13509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
478 Díaz Del Arco C, Ortega Medina L, Fernández Aceñero MJ. Histiocytic and dendritic cell neoplasms: A case series of 24 patients. Med Clin (Barc) 2017;149:456-7. [PMID: 28923676 DOI: 10.1016/j.medcli.2017.07.011] [Reference Citation Analysis]
479 Liu T, Cai HC, Cai H, Chen M, Zhang W, Li J, Zhou DB, Cao XX. Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis. Orphanet J Rare Dis 2022;17:39. [PMID: 35130950 DOI: 10.1186/s13023-022-02193-0] [Reference Citation Analysis]
480 Karamova AE, Chikin VV, Znamenskaya LF, Nefedova MA, Mikhina VA, Battalova NS. Langerhans cell histiocytosis in an adult patient. Vestnik dermatologii i venerologii 2019;95:57-66. [DOI: 10.25208/0042-4609-2019-95-4-57-66] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
481 Héritier S, Emile JF, Hélias-Rodzewicz Z, Donadieu J. Progress towards molecular-based management of childhood Langerhans cell histiocytosis. Arch Pediatr 2019;26:301-7. [PMID: 31281037 DOI: 10.1016/j.arcped.2019.05.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
482 Choi JH, Ro JY. The 2020 WHO Classification of Tumors of Bone: An Updated Review. Adv Anat Pathol 2021;28:119-38. [PMID: 33480599 DOI: 10.1097/PAP.0000000000000293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
483 Nayak L. From inflammation to cancer: entering a new frontier in the management of Erdheim-Chester disease. Neuro Oncol 2020;22:905-6. [PMID: 32343812 DOI: 10.1093/neuonc/noaa110] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
484 Radzikowska E. Update on Pulmonary Langerhans Cell Histiocytosis. Front Med (Lausanne) 2020;7:582581. [PMID: 33763431 DOI: 10.3389/fmed.2020.582581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
485 Tan MH, Foo CH, Ohn MH, Ohn KM. Experience of diagnosing and managing a patient with spinal Rosai-Dorfman-Destombes disease in a tuberculosis hyperendemic region. BMJ Case Rep 2022;15:e245360. [PMID: 35321909 DOI: 10.1136/bcr-2021-245360] [Reference Citation Analysis]
486 Nguyen PX, Nguyen NV, Le TD. Spinal extranodal Rosai-Dorfman disease: A case report and literature review. Int J Surg Case Rep 2021;88:106491. [PMID: 34656927 DOI: 10.1016/j.ijscr.2021.106491] [Reference Citation Analysis]
487 Papageorgiou SG, Divane A, Roumelioti M, Kottaridi C, Bouchla A, Georgakopoulos A, Ieremiadou F, Daraki A, Bazani E, Thomopoulos TP, Chatziioannou S, Mavrogenis A, Panayiotidis P, Panayiotides IG, Pappa V, Foukas PG. Erdheim-Chester Disease and Acute Myeloid Leukemia with Mutated NPM1 in a Patient with Clonal Hematopoiesis: A Case Report. Onco Targets Ther 2020;13:11689-95. [PMID: 33235460 DOI: 10.2147/OTT.S276497] [Reference Citation Analysis]
488 Maggio A, Climent F, Turégano P, Sirvent JJ. [Multisystem histiocytosis of Langerhans cells associated with Lymphomatoid papulosis: An accidental finding? Case report and literature review]. Rev Esp Patol 2019;52:130-5. [PMID: 30902378 DOI: 10.1016/j.patol.2018.04.004] [Reference Citation Analysis]
489 Hoyo-Muñoz A, Collado-Borrell R, Escudero-Vilaplana V, Bastos-Oreiro M, Herranz-Alonso A, Sanjurjo-Sáez M. Thalidomide as treatment of refractory thoracic Rosai-Dorfman disease. J Clin Pharm Ther 2021. [PMID: 34514634 DOI: 10.1111/jcpt.13513] [Reference Citation Analysis]
490 Machan S, Córdoba R, Carvajal N, Requena L, Piris MÁ, Facchetti F, Rodríguez-Pinilla SM. Atypical Histiocytic Lesion Preceding a Peripheral T-Cell Lymphoma Involving the Skin Exhibiting the Same Molecular Alterations. Am J Dermatopathol 2019;41:148-54. [PMID: 30085957 DOI: 10.1097/DAD.0000000000001245] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
491 Doglioni C. Rosai-Dorfman disease. A legacy of Professor Rosai that is still not exploited completely. Pathologica 2021;113:388-95. [PMID: 34837097 DOI: 10.32074/1591-951X-548] [Reference Citation Analysis]
492 Fraitag S, Lamant L. [Dermatopathology histoseminar: Introduction]. Ann Pathol 2018;38:207-9. [PMID: 29908855 DOI: 10.1016/j.annpat.2018.05.003] [Reference Citation Analysis]
493 Chen LYC, Mattman A, Seidman MA, Carruthers MN. IgG4-related disease: what a hematologist needs to know. Haematologica 2019;104:444-55. [PMID: 30705099 DOI: 10.3324/haematol.2018.205526] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
494 Wei C, Zhou DB. Long-time remission of laryngeal Rosai-Dorfman disease with thalidomide: a report of three cases. Hematology 2021;26:552-5. [PMID: 34348601 DOI: 10.1080/16078454.2021.1941552] [Reference Citation Analysis]
495 Sakr HI, Buckley K, Baiocchi R, Zhao WJ, Hemminger JA. Erdheim Chester disease in a patient with Burkitt lymphoma: a case report and review of literature. Diagn Pathol 2018;13:94. [PMID: 30474563 DOI: 10.1186/s13000-018-0772-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
496 Sbardella E, Puliani G, Feola T, Pofi R, Pirchio R, Sesti F, Verdecchia F, Gianfrilli D, Moffat D, Isidori AM, Grossman AB; Talent group. A clinical approach to parasellar lesions in the transition age. J Neuroendocrinol 2021;33:e12995. [PMID: 34138496 DOI: 10.1111/jne.12995] [Reference Citation Analysis]
497 Rajkumar K, Viswambaran M, Sen A, Chattopadhyay PK. Bisphosphonate Osteonecrosis in a Case of Langerhans Cell Histiocytosis: Report of a Case and Review of Literature. J Maxillofac Oral Surg . [DOI: 10.1007/s12663-021-01625-x] [Reference Citation Analysis]
498 Negishi K, Ishihara M, Adachi S, Komori T, Achiha T, Goto T, Nishio M. Primary histiocytic sarcoma of the central nervous system: A case report. Interdisciplinary Neurosurgery 2022;28:101522. [DOI: 10.1016/j.inat.2022.101522] [Reference Citation Analysis]
499 Misra S, Gupta K, Gupta R. Solitary adult xanthogranuloma in external auditory canal: Cyto-histopathological correlation of an uncommon entity at an uncommon site. Diagn Cytopathol 2020;48:666-9. [PMID: 32275346 DOI: 10.1002/dc.24430] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
500 Fronek LF, Grubbs H, Dorton DW, Miller R. Isolated Cutaneous Langerhans Cell Histiocytosis Presenting in an Adult Male. Cureus 2020;12:e9861. [PMID: 32963902 DOI: 10.7759/cureus.9861] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
501 Flores-terry M, Romero-aguilera G, González-lópez L, García-arpa M. Enfermedad de Rosai-Dorfman cutánea facial. Actas Dermo-Sifiliográficas 2017;108:480-2. [DOI: 10.1016/j.ad.2016.10.018] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
502 Jeon I, Choi JH. Isolated thoracic intramedullary Erdheim-Chester disease presenting with paraplegia: a case report and literature review. BMC Musculoskelet Disord 2021;22:270. [PMID: 33711983 DOI: 10.1186/s12891-021-04061-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
503 Fauser J, Köck S, Gunsilius E, Chott A, Peer A, Ditlbacher A, Fritsche G, Joannidis M, Wolf D, Pircher A. Death of unknown cause? Post-mortem diagnosis of fulminant course of an EBV-associated secondary hemophagocytic lymphohistiocytosis. Memo 2021;:1-5. [PMID: 33824685 DOI: 10.1007/s12254-021-00701-9] [Reference Citation Analysis]
504 Tarnawsky SP, Yoder MC. Neuroscience: From embryo mutation to adult degeneration. Nature 2017;549:340-2. [PMID: 28854170 DOI: 10.1038/nature23547] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
505 Milne P, Bigley V, Bacon CM, Néel A, McGovern N, Bomken S, Haniffa M, Diamond EL, Durham BH, Visser J, Hunt D, Gunawardena H, Macheta M, McClain KL, Allen C, Abdel-Wahab O, Collin M. Hematopoietic origin of Langerhans cell histiocytosis and Erdheim-Chester disease in adults. Blood 2017;130:167-75. [PMID: 28512190 DOI: 10.1182/blood-2016-12-757823] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 14.0] [Reference Citation Analysis]
506 Wang BB, Ye JR, Li YL, Jin Y, Chen ZW, Li JM, Li YP. Multisystem involvement Langerhans cell histiocytosis in an adult: A case report. World J Clin Cases 2020; 8(20): 4966-4974 [PMID: 33195668 DOI: 10.12998/wjcc.v8.i20.4966] [Reference Citation Analysis]
507 Gianella P, Dulguerov N, Arnoux G, Pusztaszeri M, Seebach JD. Thyroid Rosai-Dorfman disease with infiltration of IgG4-bearing plasma cells associated with multiple small pulmonary cysts. BMC Pulm Med 2019;19:83. [PMID: 31053123 DOI: 10.1186/s12890-019-0847-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
508 Rodriguez-Galindo C, Allen CE. Langerhans cell histiocytosis. Blood. 2020;135:1319-1331. [PMID: 32106306 DOI: 10.1182/blood.2019000934] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 15.5] [Reference Citation Analysis]
509 Chinchilla EA, Gourde MP, Turcotte K, Mathieu S, Amin-Hashem M. Case of Erdheim-Chester presenting with xanthelasma-like eruption and osteolytic bone lesions: A case report. SAGE Open Med Case Rep 2019;7:2050313X19845217. [PMID: 31105942 DOI: 10.1177/2050313X19845217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
510 Luna LP, Drier A, Aygun N, Mokhtari K, Hoang-Xuan K, Galanaud D, Donadieu J, Dormont D, Haroche J, Martin-Duverneuil N. MRI features of intra-axial histiocytic brain mass lesions. Clin Radiol 2021;76:159.e19-28. [PMID: 33077156 DOI: 10.1016/j.crad.2020.09.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
511 Wu KJ, Li SH, Liao JB, Chiou CC, Wu CS, Chen CC. NRAS Mutations May Be Involved in the Pathogenesis of Cutaneous Rosai Dorfman Disease: A Pilot Study. Biology (Basel) 2021;10:396. [PMID: 34063325 DOI: 10.3390/biology10050396] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
512 Bonometti A, Ferrario G, Parafioriti A, Giardino D, Simonetti F, Ginori A, Passoni E, Berti E; for AIRI, Associazione Italiana Ricerca Istiocitosi ONLUS. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia. J Cutan Pathol 2021;48:637-43. [PMID: 33188581 DOI: 10.1111/cup.13918] [Reference Citation Analysis]
513 Fujita Y, Fukui S, Suzuki T, Ishida M, Endo Y, Tsuji S, Takatani A, Igawa T, Shimizu T, Umeda M, Sumiyoshi R, Nishino A, Koga T, Kawashiri SY, Iwamoto N, Ichinose K, Tamai M, Nakamura H, Origuchi T, Abe K, Kawakami A. Anti-MDA5 Antibody-positive Dermatomyositis Complicated by Autoimmune-associated Hemophagocytic Syndrome That Was Successfully Treated with Immunosuppressive Therapy and Plasmapheresis. Intern Med 2018;57:3473-8. [PMID: 29984753 DOI: 10.2169/internalmedicine.1121-18] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
514 Matsukawa T, Suto K, Miyoshi H, Oshimi K, Ohshima K, Miyagishima T. Successful treatment of an elderly Langerhans cell sarcoma patient by EPOCH (etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin) chemotherapy. J Clin Exp Hematop 2018;58:184-7. [PMID: 30305476 DOI: 10.3960/jslrt.18027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
515 Rizzoli A, Giancristoforo S, Haass C, De Vito R, Gaspari S, Scapillati E, Diociaiuti A, El Hachem M. Congenital self-healing reticulohistiocytosis in a newborn: unusual oral and cutaneous manifestations. Ital J Pediatr 2021;47:135. [PMID: 34112212 DOI: 10.1186/s13052-021-01082-9] [Reference Citation Analysis]
516 He S, Jin K, Deng X, Zhou Z, McKinstry RC, Wang Y. Imaging features of neonatal systemic juvenile xanthogranuloma: a case report and review of the literature. J Int Med Res 2020;48:300060520956416. [PMID: 32981400 DOI: 10.1177/0300060520956416] [Reference Citation Analysis]
517 Bellizzi AM, Montgomery EA, Hornick JL. American Registry of Pathology Expert Opinions: Evaluation of poorly differentiated malignant neoplasms on limited samples - Gastrointestinal mucosal biopsies. Ann Diagn Pathol 2020;44:151419. [PMID: 31786484 DOI: 10.1016/j.anndiagpath.2019.151419] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
518 Stathi D, Yavropoulou MP, Allen CE, Abhyankar H, Scull B, Tsoli M, Andreakos E, Kaltsas G, Makras P. Prevalence of the BRAF V600E mutation in Greek adults with Langerhans cell histiocytosis. Pediatr Hematol Oncol 2022;:1-9. [PMID: 35139731 DOI: 10.1080/08880018.2022.2029988] [Reference Citation Analysis]
519 Bastianpillai J, Haloob N, Panchappa SA, Marais J. The Rare Case of an Adult-Onset Xanthogranuloma of the Paranasal Sinuses: A Histological Dilemma. Case Rep Pathol 2020;2020:2847821. [PMID: 32566345 DOI: 10.1155/2020/2847821] [Reference Citation Analysis]